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Abstract
Aquaculture is vital for the global food supply, but the high incidence of
infectious diseases threatens the industry’s productivity. The intestinal mucosa is a key
port of entry for pathogens and provides an extensive interface for host-microbe
interactions. Tight junctions are at the core of gut barrier function and the mucosal health
of finfish. Disruption of these complexes gives rise to sepsis, which leads to systemic
inflammation and death. The present study employs a combinatorial approach that
integrates in vitro and in vivo analyses to gain actionable insights into the mechanism of
microbial-mediated modulation of host health. The experiments outlined in chapters 2
and 3 examine the suitability of several candidate probiotics for promoting gut barrier
function, immunity, and mitigating the deleterious effects of the highly virulent aquatic
pathogen Vibrio anguillarum. These studies demonstrate the importance of investigating
the mechanism underlying host-microbe and microbe-microbe interactions for
maximizing salmonid health.

Keywords
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Summary for lay audience
The aquaculture industry, which refers to the farming of aquatic species, is rapidly
growing and its production has far surpassed that of capture hatcheries. Given that the
human population will continue to increase, aquaculture must intensify its practices in the
coming years to ensure the security of the global food supply. However, there are several
interdependent factors that negatively impact the industry’s ability to meet these growing
demands. These include competition for natural resources, climate change, and infectious
diseases. The latter has become a major limiting factor for further intensification of
production, and despite great developments over the past three decades, viral and
bacterial infections continue to cause multibillion-dollar losses for the industry every
year. Microbes are ubiquitous both within and around fish. In addition to its role in
digestion, the intestinal mucosa is home to the richest and most abundant community of
resident microbes that can interact with the host cells and modulate health. This interface
is also a target site for the onset of infection, but supplementation of probiotic bacteria
has reportedly improved disease resistance and overall physiology in several fish species.
In this thesis, the concept of using beneficial microbes for the improvement of host health
by interacting with the intestinal epithelium was explored with the focus on salmonid
species, which are the most economically important family of finfish. By using a cellbased laboratory model of the salmonid intestine, it was found that the candidate fish
probiotics could protect the cells from the highly virulent fish pathogen Vibrio
anguillarum, but the beneficial microbes had no effect on the expression of key gut
barrier and immune molecules. To investigate these concepts in live animals, a disease
trial was carried out at a fish farm in British Columbia. Chinook salmon were fed with
iii

diets containing different probiotic strains and were then infected with the pathogen V.
anguillarum. It was found that probiotic supplementation had no effect on the survival,
growth, or gene expression of immune or gut barrier molecules in the intestinal tissue.
This project established the use fish cell lines for the investigation of host-microbe
interactions and represents a steppingstone to guide future researchers on the study of
more suitable candidate fish probiotic strains.
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Epigraph

'Oh, the depth of the riches both of the wisdom and knowledge of God!
How unsearchable are His judgments and His ways past finding out!
“For who has known the mind of the LORD?
Or who has become His counselor?”
“Or who has first given to Him, and it shall be repaid to Him?”
For of [Christ] and through [Christ] and to [Christ] are all things, to
whom be glory forever. Amen.'

Romans 11:33-36 NKJV

vi

Dedication

For Mom, Dad, Brother, and Matt.
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Chapter 1
1. General introduction
The material in this chapter has been reproduced/adapted from a review article published
in FEMS Microbiology Reviews and has a content license that can be found in Appendix
A.
Langlois L, Akhtar N, Tam CK, Dixon B, Reid G. Fishing for the right probiotic: Hostmicrobe interactions at the interface of effective aquaculture strategies. 2021. FEMS
Microbiology Reviews.

1.1 Abstract
Effective aquaculture management strategies are paramount to global food
security. Growing demands stimulate the intensification of production and create the need
for practices that are both economically viable and environmentally sustainable.
Importantly, pathogenic microbes continue to be detrimental to fish growth and survival.
In terms of host health, the intestinal mucosa and its associated consortium of microbes
have a critical role in modulating fitness and present an attractive opportunity to promote
health at this interface. In light of this, the administration of probiotic microorganisms is
being considered as a means to restore and sustain health in fish. Current evidence
suggests that certain probiotic strains might be able to augment immunity, enhance
growth rate, and protect against infection in salmonids, the most economically important
family of farmed finfish. This review affirms the relevance of host-microbe interactions
in salmonids in light of emerging evidence, with an emphasis on intestinal health. In
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addition, the current understanding of the mode of action of probiotics in salmonid fish is
discussed, along with delivery systems that can effectively carry the living microbes.

1.2 Introduction
Aquaculture refers to the farming of aquatic species, including finfish, shellfish,
crustaceans, and plants, primarily for human consumption. This is the fastest-growing
sector in the livestock industry and is responsible for the production of over 50% of the
fish consumed worldwide (FAO 2020). A conservative estimate by the United Nations’
Food and Agriculture Organization (FAO) is that an additional 40 million tonnes of fish
protein will be needed to feed the human population by 2030 (FAO 2020). As such,
aquaculture production must be intensified to meet growing global demands and prevent
irreversible losses in biodiversity due to overfishing of wild populations. It is, therefore,
essential that the practices employed are environmentally safe and sustainable, while
remaining economically viable.
Salmonids, such as trout and salmon species, represent the largest single fish
commodity by value in the aquaculture world trade (FAO 2020). The salmonid market is
currently dominated by farming of Atlantic salmon (Salmo salar), followed by rainbow
trout (Oncorhynchus mykiss). Other members of the Salmonidae family include other
trout and char (Salvelinus sp.) species, as well as Pacific species, such as Chinook salmon
(Oncorhynchus tshawytscha) (FAO 2020). Salmonids attract high market values because
they are a stable source of quality fish protein, as well as a versatile raw material that can
be processed into a wide range of food products (Merrifield et al. 2010). These features
have amplified the interest in commercial farming, which greatly increased global
production of these species in the last 20 years (FAO 2020).
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To date, scientific research has largely focused on the genetics of elite broodstock
management, nutrition, and the health of salmonids. Challenges remain, especially as
they pertain to infectious diseases that afflict these fish. The high incidence of infectious
diseases creates a substantial financial burden and instability for the farmers. With losses
that surpass US$6 billion annually worldwide, aquaculturists are left with limited options
to prevent and combat outbreaks (Brummett et al., 2014). Current strategies consist
primarily of prophylactic antibiotic administration; however, their use is highly
discouraged due to the rise in multidrug-resistant bacterial strains (Verschuere et al.,
2000; Watts et al., 2017; Santos and Ramos, 2018).
In addition, antibiotics disrupt the microbiota of fish, and this in turn can increase
the susceptibility to secondary infections (He et al. 2017). For example, administration of
oxytetracycline has been shown to cause dysbiosis in the intestinal microbiota of juvenile
Atlantic salmon (Navarrete et al. 2008). Similarly, in zebrafish, sub-therapeutic doses of
olaquindox, an antibiotic growth promoter commonly used in aquaculture, led to a trend
of higher mortality after Aeromonas hydrophila challenge. This phenomenon was
associated with a profound shift in the microbiota composition of the antibiotic-treated
group from a Fusobacteria- to a Proteobacteria-dominated community, which suggests
that antibiotic-induced disruptions in the gut microbiota can increase the susceptibility to
secondary infections (He et al. 2017).
Vaccination is also widely used, albeit with limited efficacy. The undercharacterization of finfish immunology makes vaccine design challenging; the immature
adaptive immune response in juvenile finfish makes them unsuitable for vaccination,
leading to high mortality rates due to infections; and vast host genetic variability
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contributes to poor protection between fish families (Dixon 2012; Pérez-Sánchez, MoraSánchez and Balcázar 2018; Figueroa et al. 2020). These sub-optimal outcomes have
fuelled an interest in alternative eco-friendly strategies, such as the use of microbialbased therapeutics, that can mitigate losses due to infectious diseases and improve the
value chain of fish production.
The intestinal mucosa and microbiota are critical to host health, locally and at
distant sites. These findings are also relevant to fish species, given that nutrient
absorption, immunity, and prevention of infection also occur at this interface (Merrifield
et al., 2010; Jutfelt 2011). Likewise, high-quality animal nutrition is vital for growth,
immune competence, disease resistance, and stress mitigation (Ringø et al. 2016).
Approximately half of the costs associated with aquaculture are directly related to feed
and nutrition. Thus, strategies that maximize feed conversion rates and prevent additional
costs related to infectious disease outbreaks have become an industry priority (FAO
2018).
There is a growing trend towards the use of dietary supplements that can promote
health and limit pathogens at the gastrointestinal interface. Given the importance of
microbes in the gut, the concept of supplementing beneficial ones (probiotics) is being
considered. Probiotics are ‘live microorganisms that, when administered in adequate
amounts, confer a health benefit on the host’ (Hill et al. 2014). In fish, attempts at using
probiotics have been reported to promote growth, improve feed conversion rates, enhance
immune function and disease resistance, and counter pathogens (Gram et al. 1999; Wang,
Li and Lin 2008; Zorriehzahra et al. 2016).
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The purpose of this review is to discuss the impact of host-microbe interactions in
salmonids, particularly those associated with intestinal health. This will also include an
overview of the different mechanisms of action of probiotics in salmonids, and a survey
of vehicles for their delivery in aquaculture systems. Although several reviews have
addressed some of the aspects herein discussed, to our knowledge, none have
endeavoured to integrate the host-microbe interactions specifically in farmed salmonids,
as well as key knowledge gaps to be addressed in the field. The aquaculture industry
stands at a new frontier of sustainable intensification of production and an amplified
interest in alternative rearing systems, such as Norway’s land fish farms (Gibson 2021).
This article is particularly timely to inform research and development of salmonid
production and contribute to the optimization of aquaculture strategies through microbialmediated modulation of host health.

1.1.1 Salmonid intestinal microbiome
The microbial ecosystems inhabiting all mucosal surfaces in fish have a key role
in the modulation of host fitness. Studies have shown that microbial counterparts vastly
outnumber their host cells, and the metabolic capacity of this community facilitates
processes vital for host health and homeostasis (Qin et al. 2010). Recent efforts have
examined the taxonomical composition of the intestinal microbiota of some fish species,
its functional stability over time, and the response to physiological stimuli, such as
stressors, infectious diseases, and nutrition (Wang et al. 2018a).
Using next-generation sequencing (NGS) technologies and high-throughput
analyses, the composition and function of the microbiota can be identified. Early efforts
have revealed the presence of a strikingly similar ‘core microbiota’ comprised mainly of
5

γ-Proteobacteria and Fusobacteria in zebrafish shared between laboratory-reared and
wild-caught fish (Roeselers et al. 2011). This suggests that laboratory studies could be
relevant to fish in the wild in terms of their microbiome, and that host selective pressures
might play a central role in determining the composition of this microbial community in
fish. Although the gut microbiota of Atlantic salmon along disparate sampling sites share
80% of their composition, there are still substantial differences between the intestinal
mucosa and digesta, which might suggest that spatial microbe groupings have evolved to
exert different functions due to their proximity with the epithelial interface (Gajardo et
al., 2016). The phyla Proteobacteria and Firmicutes were found to be present in highest
abundance in the gut, primarily represented by members of the Pseudomonas,
Acinetobacter, Microbacterium, Janthinobacterium, and Burkholderia genera (Gajardo et
al., 2016).
More recently, the microbial composition in the water, feces, and feed were
compared for Chinook salmon in a seawater recirculation aquaculture system (Steiner et
al. 2021). The study found overlaps between microbes in all three ecosystems, with the
feces having the highest microbial abundance and richness. The core microbiota in the
feces was comprised mainly of the phyla Firmicutes, Proteobacteria, Bacteriodetes, and
Actinobacteria which is in line with other reports in salmonids (Gajardo et al., 2016; AlHisnawi et al., 2019). However, without distinguishing ‘healthy’ versus ‘dysbiosis’
states, it will be difficult to develop tools to rapidly diagnose and mitigate the
uncontrolled expansion of pathobionts in the fish gut.
Lactic acid bacteria (LAB), known to be associated with health in humans and
other species (Trinder et al., 2015; Puebla-Barragan and Reid, 2019), are also common
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residents of the salmonid gut (Gajardo et al., 2016; Al-Hisnawi et al., 2019).
Interestingly, an increased abundance of LAB, such as Leuconostoc and Weissella, in the
distal gut of salmon is associated with plant-based diets and is, at least in part, affected by
seasonal changes (Zarkasi et al., 2014; Gajardo et al., 2016). In winter, LAB are more
abundant, whereas members of the Vibrionaceae and Pseudomonaceae families, which
contain pathogens able to cause opportunistic infections, increase in abundance in
warmer months (Hatje et al., 2014; Zarkasi et al., 2014, 2016; Gajardo et al., 2016).
Temperature has a fundamental effect on bacterial growth as well as host physiology.
Therefore, as the water temperature changes, some taxa lose competitiveness and their
depletion allows others to take their place (Zarkasi et al. 2014). This provides an
opportunity to test the concept of seasonal supplementation of probiotic organisms that
counter these pathogens by administering them just prior to summer.
As anadromous fish, salmonids experience significant habitat transitions, which is
reflected by considerable changes in the composition of the intestinal microbiota. The
intestine of saltwater (SW) Atlantic salmon has a greater abundance of Firmicutes, as
well as increased bacterial load, higher alpha diversity, and lower beta diversity
compared to freshwater (FW) fish (Rudi et al. 2018). In spite of these differences, several
reports point towards the presence of a ‘core’ gut microbiota shared among different
conditions, such as FW to SW transition, diets, rearing densities, geographic location, and
wild vs. captive-reared fish (Sullam et al. 2012; Wong et al. 2013; Zarkasi et al. 2014,
2016; Gajardo et al. 2016; Llewellyn et al. 2016; Rudi et al. 2018; Steiner et al. 2021).
These core microbe assemblages are highly adapted to the salmonid intestinal ecosystem
and occupy ecological niches in a symbiotic relationship with their hosts. The host
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provides shelter and nutrients, and the microbes facilitate key metabolic processes and
help reduce infection. The remarkable adaptability of this core microbiota points to a
functional niche that these microbes have evolved to fulfill by being in close association
with the host. The administration of antibiotics, whether prophylactically or as a
treatment, disrupts this core community causing a significant rearrangement of the
ecological composition and function. Ironically, a consequence is that nutritional and
ecological niches harbouring beneficial microbes are vacated due to antibiotics and
invariably filled by pathobionts (Gatesoupe 2008).
The high-resolution characterization of the salmonid gut microbiota and the
mapping of factors that affect this community provide important insights into the
relationships between host and microbe. However, the functional significance of these
changes for host health remains largely unclear. As such, multi-omics studies are needed
to identify which microbial associations equate with health-promoting metabolic function
in fish and how detrimental associations can be manipulated (Uengwetwanit et al. 2020).
Furthermore, shotgun deep-sequencing and metabolomic analyses can provide a more
comprehensive framework of the taxonomy and metabolic potential of the salmonid
microbiome, thus paving the way for actionable insights derived from such analyses.

1.1.2 Intestinal mucosa at the interface of fish health
The intestinal mucosa was once regarded simply as a digestive organ. In fish, it
has been proposed that differences in immune competence are related to the ability to
prevent pathogen attachment and invasion at mucosal tissues (Palaksha et al., 2008;
Rajan et al., 2011; Gao et al., 2016). It is estimated that the distal intestine harbours
between 107-108 CFU/g of intestinal content, which constitutes the most prominent
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microbial community in terms of richness and abundance (Austin 2006; Gómez and
Balcázar 2008).
The continual exposure to commensal and transient microbes at mucosal surfaces
creates the need for mechanisms that provide broad-range protection for the host. In the
gut, a layer of mucus offers the first line of defence. It contains several antimicrobial and
protective compounds, including antibodies, complement components, enzymes,
antimicrobial peptides, and mucins (Zou et al., 2007; Brunner et al., 2020). The gutassociated lymphoid tissue (GALT) has additional mechanisms which include diffusely
organized lymphoid cells, granulocytes, macrophages, and mucus IgM and IgT antibodies
to distinguish between commensal microbes and provide broad-range protection against
potential pathogens (Zhang et al., 2010; Lazado and Caipang, 2014; Salinas and Parra,
2015). The mucosal tolerance to microbes in the gastrointestinal tract promotes
homeostasis in the commensal community while simultaneously limiting the expansion
of opportunistic pathogens.
The intimate relationship between host and microbe begins as soon as the eggs are
laid (Yoshimizu, Kimura and Sakai 1980). During development, the resident microbes
promote epithelial cell growth and differentiation, as evidenced by studies in gnotobiotic
zebrafish (Danio rerio) embryos. Germ-free (GF) zebrafish were found to have immature
gastrointestinal tracts and a significantly lower population of epithelial cells actively
proliferating compared to the conventional-reared embryos (Rawls et al., 2004; Bates et
al., 2006). Additionally, several genes related to cell proliferation, nutrient metabolism,
and innate immunity were differentially expressed in GF versus conventional-reared
embryos (Rawls, Samuel and Gordon 2004). These findings highlight the profound
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codependence between host and microbiota for proper gastrointestinal development. A
more recent study accordingly found that gnotobiotic rainbow trout larvae had fewer
Goblet cells compared to their conventionally-reared counterparts (Perez-Pascual et al.
2021). In rainbow trout and Coho salmon (Oncorhynchus kisutch), the core phyla of
microbes present throughout their life cycle stably colonize the gastrointestinal tract upon
first feeding (Romero and Navarrete, 2006; Ingerslev et al., 2014). As such, these resident
microbes help stimulate immune cells and establish mucosal tolerance through the
presentation of antigens by the microbiota, which prime the immune system and promote
maturation of the GALT (Gomez, Sunyer and Salinas 2013).
One could rightly ask if these core microbiota assemblages have evolved over
time to optimally prime the host’s gastrointestinal and immune functions, why do they
not protect the fish from disease and poor nutritional uptake? The answer is not known,
but the presumption is that external anthropogenic factors such as pollutants, pathogens,
stress, and artificial food sources alter the microbiota composition and metabolic output,
thus leading to diminished health.

1.1.3 Infectious diseases in aquaculture and the threat posed by
Vibrio anguillarum
As is the case in other forms of farming, aquaculture animals are reared in settings
that differ substantially from those in the wild. The combination of several factors, such
as chemical stress (e.g. water quality, diet), biological stress (e.g. high rearing densities
and increased abundance of microorganisms), and physical stress (e.g. temperature
fluctuations) creates a formidable environment for opportunistic pathogenic infections
(Frans et al. 2011). Accordingly, the shift from extensive (low stocking densities, no
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exogenous feeding) to more intensive (higher stocking densities and artificial feeding)
forms of aquaculture has been associated with a dramatic increase in the incidence and
severity of disease outbreaks, which leads to devastating economic losses (Bayliss et al.
2017).
The following bacterial pathogens particularly affect salmonids: Aeromonas
salmonicida (furunculosis), Vibrio anguillarum (vibriosis), Vibrio salmonicida (cold
water vibriosis), Piscirickettsia salmonis (piscirickettsiosis), Yersinia ruckeri (enteric red
mouth disease/yersiniosis), Renibacterium salmoninarum (bacterial kidney disease),
Flavobacterium psychrophilum (bacterial cold water disease), Lactococcus garviae
(lactococcosis), and Moritella viscosa (winter ulcer; Merrifield et al., 2010). Although
these pathogens differ in their disease presentation, their ability to translocate the
intestinal epithelium is a key route of entry to the blood (Ringø et al., 2003; Jutfelt et al.,
2006; Figure 1-2). Thus, the survival advantage provided by probiotic supplementation
has been attributed, at least in part, to enhancement of immune and barrier function
(Ringø et al., 2007a, 2007b; Salinas et al., 2008; Nayak, 2010; Table 1-1). Notably,
evidence also suggests an important role for microbe-microbe interactions in probiotic
strains reducing pathogen adherence to mucosal surfaces, limiting growth through
nutrient exclusion, antagonising the pathogens through the secretion of antimicrobial
molecules, or lowering the local pH (Ringø et al., 2020; Figure 1-1).
The pathogen Vibrio anguillarum is particularly concerning to the aquaculture
industry due to its virulence, widespread prevalence, and wide range of targets (Frans et
al. 2011). This species is ubiquitously found in saltwater, freshwater, and brackish water
worldwide and infects over 50 fish species of economic importance to the aquaculture
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industry, including finfish and shellfish species (Frans et al. 2011). The pathogen is a
Gram-negative, non-spore-forming, comma-shaped rod bacterium (Toranzo, Magariños
and Romalde 2005; Frans et al. 2011). The bacterium bas a 4.2Mb bipartite genome with
a 43-46% GC content and a 65-67Kb virulence plasmid, pJM1 and other newly-identified
pJM1-like plasmids (Naka and Crosa 2011; Akter et al. 2020).
The pJM1 plasmid is an essential component in V. anguillarum’s virulence and
pathogenicity, as pMJ1-less O1 strains were more sensitive to lysozyme, were unable to
colonize the skin, but could still colonize the gut with limited motility and could not
transport the ferrin-anguibactin complex into the cell (Weber, Chen and Milton 2010).
This organism’s arsenal of virulence factors includes a flagellum for chemotaxis and
motility (Milton et al. 1996; O’Toole, Milton and Wolf-Watz 1996), proteases (Norqvist,
Norrman and Wolf-Watz 1990), hemolysin activity (Hirono, Masuda and Aoki 1996),
and an iron-sequestering mechanism (Crosa et al. 1985). There are 23 known O serotypes
(O1–O23), of which only serotypes O1, O2, and O3 (the latter to a lesser extent) have
been associated with disease with a distinct pathogenicity and host specificity in fish
species (Pedersen et al. 1999).
Vibriosis is characterized by a highly fatal haemorrhagic septicaemia, and clinical
signs include weight loss, lethargy, redness on the skin, abdominal distension,
liquefaction of organs, exophthalmia, and haemorrhaging in the gills and fins (Toranzo,
Magariños and Romalde 2005; Frans et al. 2011). High bacterial concentrations are found
in the blood and haematopoietic tissues during infection (Frans et al. 2011). Importantly,
in acute epizootic infection, fish may succumb to the disease prior to demonstrating
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classical symptoms due to rapid disease transmission, which directly translates to
substantial economic losses to the farmers (Frans et al. 2011).
Regarding the mode of entry of the pathogen, evidence suggests that V.
anguillarum infects the host through the skin and gills, as well as through ingestion of
contaminated food and water. It then localizes, initially to the distal gut, prior to entering
the bloodstream by translocating across the epithelial barrier (Grisez et al. 1996; Olsson
et al. 1996, 1998; O’Toole et al. 1999) (Figure 1-2). Skin colonization with the pathogen
may also play a role during infection, but it is possible that the plethora of antimicrobial
peptides keep the pathogen at bay (Weber, Chen and Milton 2010). Exposure to intestinal
mucus supports rapid growth of V. anguillarum and the bacterium becomes particularly
virulent, as several of its virulence factors are specifically induced by contact with
intestinal mucus (Garcia et al. 1997; Olsson et al. 1998; Denkin and Nelson 1999; Li et
al. 2015). Indeed, a mechanistic analysis of an infection with V. anguillarum in turbot
(Scophthalmus maximus) elicited an enrichment in pathogen adherence and attachment
with a simultaneous downregulation of intracellular pathogen recognition molecules,
which suggests immune evasion through the impairment of several innate immune
pathways in the host (Gao et al. 2016). Leukocyte respiratory burst activity and apoptotic
cascades were also downregulated in sea bass (Dicentrarchus labrax L.; Sepulcre et al.
2007). These findings further support the hypothesis that the intestine is indeed a major
portal of pathogen entry into the bloodstream.
Prevention and containment strategies consist of prophylactic measures to
promote the health and welfare of the animals, such as lower stock densities, high-quality
nutrition, and maintenance of optimal temperature. Antibiotic use, although still
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employed in some cases, is increasingly being strictly regulated against as these
compounds enrich for resistant organisms and disrupt the indigenous microbiota (He et
al. 2017). Immunization has also been investigated as a preventative strategy, albeit
insufficiently efficacious depending on the fish species as well as host genetic variability
that can impact the degree of protection provided by the vaccine (Dixon 2012; Figueroa
et al. 2020). Furthermore, commercial vaccines mainly protect fish from outbreaks
caused by serotypes O1 and O2, but serotype O3 cannot be completely prevented
(Mikkelsen et al. 2007).
More recently, phage therapy has been explored as an emerging disease control
strategy. The use of phages against V. anguillarum infection has been described with
some degree of success in zebrafish and Atlantic salmon (Higuera et al. 2013; Silva et al.
2014). However, further examination of phage-resistant strains has revealed that the V.
anguillarum phage isolated, CHOED, can exert a selective pressure to drive the
proliferation of resistant strains with enhanced virulence phenotypes (León et al. 2019).
As such, unless novel containment strategies are developed, vibriosis will continue to be
rampant in aquaculture settings.

1.3 Probiotic-mediated modulation of host health
Collectively, there has been an abundance of scientific literature underpinning the
benefits of probiotic supplementation in mammals. Despite the incorrect use of the term
‘probiotic’ by too many authors and companies who have not characterized the strain, its
properties, and proven a health benefit, there are reports in several agriculture-relevant
animals, such as cattle (McGilliard and Stallings 1998; Zhao et al. 1998), poultry
(Morishita et al. 1997), pigs (Hossain, Sadekuzzaman and Ha 2017), and honeybees
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(Daisley et al., 2019; Chmiel et al., 2020) in addition to humans showing the breadth of
applications for probiotic microorganisms. In fish, certain probiotic strains have been
reported to improve immunity, enhance growth rate, and protect against infection
(Nikoskelainen et al., 2003; Balcázar et al., 2007a; Vendrell et al., 2007).
There appears to be primarily two modes of action, including direct modulation
of host physiology at the mucosal interface, and indirect alteration of the structure and
function of the microbial community in the gut, which limits the expansion of pathogens
and promotes homeostasis in this community (Iman et al., 2013; Gatesoupe, 2016). Here,
the latest findings are reviewed regarding the mode of action of probiotic microorganisms
in salmonids, with an emphasis on intestinal health, in the hope of identifying strategies
to leverage microbial-mediated interventions that contribute to maximizing productivity
in the industry.
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Figure 1-1. Schematic of the concerted mechanism of action of probiotics in
salmonid fish. Probiotic microorganisms are believed to promote host fitness primarily
via the direct modulation of innate immunity and through the maintenance of epithelial
integrity. Indirect mechanisms include the production of metabolites, such as SCFAs, that
promote homeostasis in the gut commensal community, and the inhibition of pathogen
growth and expression of virulence factors. The harmonized effect is the improvement in
intestinal barrier function, which in turn has substantial physiological benefits for the
host.

1.2.1 Intestinal barrier function in salmonids
At the core of the intestinal mucosa is a single layer of epithelial cells and their
intercellular junctions (comprised of tight junctions, desmosomes, adherens’ junctions,
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and gap junctions). This complex network exerts a dual function of ‘fence’ and ‘gate’, in
which the ‘fence’ function refers to the preclusion of most of the microbes and
metabolites to the lamina propria and the gut-associated immune system while
simultaneously allowing for the absorption of nutrients, which refers to the ‘gate’
function (Clayburgh, Shen and Turner 2004; Rajasekaran, Beyenbach and Rajasekaran
2008; Suzuki 2013; Wells et al. 2017).
Low-grade inflammation resulting from a faulty intestinal barrier is being
increasingly recognized as the basis for a myriad of chronic and autoimmune conditions
in humans (Ukena et al., 2007; Bron et al., 2017). Importantly, a ‘leaky’ gut barrier may
lead to deficits in nutrient absorption and impaired immunity due to the continuous
stimulation by the passage of antigens from the intestinal lumen to the lamina propria and
portal blood (Kosińska and Andlauer 2013). As such, the gut barrier plays a critical role
in organismal health, and damage to the intestinal integrity can have significant systemic
consequences.
Probiotic strains can act at this interface and upregulate the expression of tight
junction molecules, such as claudins, occludins, and zonula occludens 1 (ZO-1). This
activity enhances intestinal barrier integrity against chemical- or pathogen-induced insults
to the epithelium (Ringø et al., 2007a; Ukena et al., 2007; Patel et al., 2012; Vasanth et
al., 2015; Wang et al., 2018b). The precise mechanism of action remains to be elucidated,
but evidence suggests that microbial metabolites, such as short-chain fatty acids (SCFAs),
can promote intestinal integrity (Mariadason, Barkla and Gibson 1997). These
compounds are a product of anaerobic fermentation of carbohydrates in the gut and are
comprised primarily by propionate, butyrate, and acetate (Ganapathy et al. 2013). This
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class of metabolites is the most important microbial end-product both quantitatively and
metabolically, and displays pleiotropic links with the maintenance of community
homeostasis and host health (Louis, Hold and Flint 2014; Rivière et al. 2016). Notably,
butyrate has been shown to promote epithelial barrier function in a human colon
carcinoma (Caco-2) epithelial cell model by suppressing the expression of proteins
associated with gut permeability, facilitating assembly of TJ complexes, and modulating
the epigenetic landscape in host cells (Peng et al., 2009; Chang et al., 2014; Kelly et al.,
2015; Zheng et al., 2017). In salmonids, dietary butyrate has been shown to upregulate
the expression of tight junction molecules and innate immune parameters in vivo
(Hoseinifar, Sun and Caipang 2017; Mirghaed et al. 2019). These studies are beginning
to unravel the complex relationship between host and microbe and how microbial
metabolites can promote intestinal integrity, although more research is warranted to
identify strains that produce butyrate in situ in the salmonid gut.
The in vivo evidence accumulated to date substantiates the concept of the
intestinal barrier as a key factor in host health. Therefore, if probiotic strains can improve
barrier function in salmonids, premature deaths and morbidity could be reduced and
nutrient uptake increased, resulting in a higher yield of commercial fish (Figure 1-1).

1.2.2 Growth and nutrition
Given that the quality and quantity of fish protein is central to aquaculture
productivity, growth promotion is arguably one of the most appealing outcomes of
probiotic supplementation for the industry. Indeed, there are some data suggesting that
supplementation of beneficial microbes positively affects growth parameters in several
salmonid species. For example, a report investigating the differences between the gut
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microbiota composition of slow- and fast-growing rainbow trout indicated that the fast
growers had a higher proportion of Firmicutes, whereas slow growers had a community
dominated by members of the Actinobacteria phylum, which is known to include
pathobionts in fish (Chapagain et al. 2019). These findings substantiate the idea that gut
microbes play a central role in modulating nutrient absorption, metabolism, and
immunity. Identification of specific members of the community responsible for the
growth advantage could lead to new probiotic products.
In Atlantic salmon, rainbow trout, and Caspian trout (Salmo trutta caspius), diets
containing Lacticaseibacillus (formerly Lactobacillus rhamnosus GG; Zheng et al., 2020)
Lactiplantibacillus plantarum CLFP 238 and Leuconostoc mesenteroides CLFP 196 plus
L. plantarum, led to improved specific growth and feed conversion ratios (Nikoskelainen
et al., 2001; Vendrell et al., 2007; Ramos et al., 2015). One of the mechanisms through
which these probiotics strains achieve physiological changes is presumed to be
modulating the expression of tight junction molecules at the intestinal mucosal surface,
though further studies are warranted (Figure 1-1). The modulation of the inflammatory
and stress responses, as well as the microbial metabolism of otherwise indigestible
nutrients, may also play an important role in fish growth and nutrient assimilation.
Central to nutrition is the quality of the diet that the fish receive. Salmonids thrive
on a diet rich in fishmeal (FM) and fish oil. However, given the intensification of
salmonid aquaculture, producers are shifting to less costly sources of protein, such as
soybean or insect meal (Rana, Siriwardena and Hasan 2009). An unintended consequence
of the use of plant-derived proteins, particularly saponins, is that they can cause
enteropathy in salmonids, as evidenced by considerable damage to the intestinal
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epithelium, the upregulation of proinflammatory cytokines, as well as appreciable
alterations in the gut microbiota, indicative of dysbiosis (Dimitroglou et al., 2009;
Marjara et al., 2012; Green et al., 2013; Krogdahl et al., 2015).
The deleterious effects induced by antinutrients might be mitigated by probiotic
administration. In rainbow trout, supplementation of a multi-strain commercial product
containing strains of Saccharomyces cerevisiae, Enterococcus faecium, L. acidophilus, L.
casei, L. plantarum, and L. brevis, in conjunction with soybean meal, rescued the deficits
in growth observed in the soybean-only diet. Furthermore, the fish fed with this product
and soybean meal starter diets exhibited higher digestibility and growth during grow-out
phases compared to starter diets devoid of the microbes (Sealey et al. 2009). These
findings suggest that certain microbes can promote intestinal health and prevent injury
induced by antinutrients. Notably, however, these effects were not observed long-term
following cessation of supplementation, presumably because the strains did not colonize
the intestinal tract (Sealey et al. 2009). Similar studies are warranted to identify strains of
beneficial microbes that support digestion and protect intestinal health from antinutrients.
In addition, research is needed to determine the optimal inclusion ratio of plant-derived
proteins in fish diets, which can help reduce the industry’s dependence on marine harvest
to produce fish feeds.
Recently, Rimoldi et al. (2021) investigated the effect of an insect meal (IM) diet
on the gut microbiota of rainbow trout and found that a 15% inclusion ratio preferentially
enriched Firmicutes, primarily represented by Bacillus and Lactobacillus genera, while
decreasing the abundance of Aeromonas, compared to a conventional FM diet. An
analysis of the metagenome revealed functional differences between treatments in the IM
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diet, indicating an enhancement of sugar and starch metabolism pathways; whereas the
FM diet enriched for peptidoglycan synthesis pathways. These data suggest that
alternative protein sources can directly modulate the gut microbiota through nutrient
availability, and thereby modify the function and metabolism to enhance digestion and
nutrient assimilation, thus benefiting the host. Increased attention should be given to the
effects of alternative diets and probiotic feed additives to preferentially enrich for key
microbes and pathways that can maximize host health.
A number of prebiotic compounds have been used to stimulate growth of
beneficial microbes in the gut. Prebiotics are defined as “a substrate that is selectively
utilized by host microorganisms conferring a health benefit” (Gibson et al. 2017), and
synbiotics as “a mixture comprising live microorganisms and substrate(s) selectively
utilized by host microorganisms that confers a health benefit on the host” (Swanson et al.
2020). The latter includes complementary synbiotics and synergistic synbiotics where the
substrate is selectively utilized by the co-administered microorganisms. A product
containing a plant- or insect- derived compound and probiotic could well be an option
worth considering to support a healthy gut microbiota and the expansion of beneficial
strains, thus leading to improved fish health.

1.2.3 Immune performance
Immune modulation is among the most widely studied effects of probiotic
supplementation in aquatic and terrestrial organisms. In fish, probiotic supplementation
augments the innate immune response through the modulation of both cellular and
humoral parameters, thereby promoting more efficient pathogen clearance and improving
disease resistance (Nayak, 2010; Table 1). Several reviews address this topic specifically
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(Nayak, 2010; Hoseinifar et al., 2018; Ringø et al., 2018). For instance, the
administration of LAB (Lc. lactis subsp. lactis CLFP 100, L. sakei CLFP 202, and Leuc.
mesenteroidetes CLFP 196) to brown trout (Salmo trutta) led to an upregulation of nonspecific humoral responses, such as lysozyme and alternative complement activities
(ACH50), as well as plasma immunoglobulin levels (Balcázar et al. 2007a). This
outcome was also observed in rainbow trout fed with Lacticaseibacillus rhamnosus JCM
1136. Interestingly, the authors noted an upregulation of non-specific humoral immunity
when the probiotic was administered in live spray or freeze-dried forms, but not when
they were heat-killed. This highlights the importance of metabolically active beneficial
microbes during gastrointestinal transit (Panigrahi et al. 2004). The same group found
that administration of a microbial mix (containing three strains of Lacticaseibacillus
rhamnosus, Enterococcus faecium, and Bacillus subtilis) increased superoxide anion
production in the head kidney leukocytes and ACH50 in the serum, along with an
upregulation of il1β, tnf1, tnf2, and tgfβ in the spleen and head kidney (Panigrahi et al.
2007).
Additionally, injection of a candidate probiotic strain of Enterobacter spp. led to
reduced mortality upon infection with Flavobacterium psychrophilum, potentially
mediated by cross-reactive antibodies generated in response to the microbial supplement,
also in rainbow trout (LaPatra, Fehringer and Cain 2014). Unfortunately, it is not clear
why that strain was chosen, as it is not a species customarily used in probiotic
applications. Another species more commonly regarded as a human pathogen, E. faecalis,
was shown to increase mucus production in rainbow trout and Pediococcus acidilactici
MA18/5M upregulated IgT expression in the gut, which is a mucosal antibody known to
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promote homeostasis in the gut microbiota (Rodriguez-Estrada et al., 2013; Al-Hisnawi et
al., 2019). Further, dietary supplementation of P. acidilactici MA18/5M locally
stimulated an increase in the levels of il1 and il8 while decreasing il10 expression in the
distal intestine, and simultaneously preserving the intestinal epithelium from detrimental
injury (Al-Hisnawi et al. 2019). Further studies with P. acidilactici MA18/5M showed
induction of an innate antiviral response in Atlantic salmon by upregulating the
expression of toll-like receptor 3, interferon-alpha, and other molecules upstream of the
cascade of the primary antiviral response (Abid et al. 2013; Jaramillo-Torres et al. 2019).
Administration of rainbow trout with a yeast supplement containing strains of
Saccharomyces cerevisiae and Cyberlindnera jardinii upregulated the expression of
molecules associated with toll-like receptor 2 signalling, effector cytokines, and
transcription factors upstream of the T cell regulatory response in the rainbow trout distal
intestine. Supplementation induced the expression of proinflammatory molecules such as
tnfα and il1β, as well as anti-inflammatory cytokines such as il10 and tgfβ, indicative of a
balance between immune stimulation and mucosal tolerance presumably mediated by
glycans, glycolipids, and glycoproteins in the fungal cell wall. In addition, supplemented
fish had significant increase in Goblet cell density, which suggests that the yeast can
stimulate increased antigen uptake and immune surveillance (Rawling et al. 2021). Such
studies investigating the molecular mucosal response to beneficial microbes are
beginning to unravel the mechanism underlying cellular and humoral immune
stimulation.
In general, the evidence from human studies suggests that probiotic strains elicit a
regulatory response that leads to immune homeostasis (Bron, Van Baarlen and
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Kleerebezem 2012). This is achieved through microorganism-associated microbial
pattern-pattern recognition receptor (MAMP-PRR) interactions that activate the nuclear
factor kappa beta (NFκB) pathway (Rescigno 2010). This, in turn, activates GALT cells
that secrete cytokines, such as tumour growth factor beta (TGFβ) and interleukin (IL) 10,
which modulate the activation and differentiation of T cells, while downregulating
proinflammatory cytokines (Lorea Baroja et al., 2007; Bron et al., 2012). In contrast,
probiotic supplementation in salmonids elicits a proinflammatory response, typically
characterized by the upregulation of IL-1β, IL-6, IL-8, and tumour necrosis factor alpha
(TNF-α) in the gut (Kim and Austin 2006a, 2006b; Panigrahi, Viswanath and Satoh 2011;
Ringø et al. 2018). Although some LAB strains induce an upregulation of IL-10 in other
finfish (Beck et al. 2016; Maji et al. 2017). This inflammatory response in salmonids is
directly correlated with a survival advantage against pathogenic challenges (Table 1),
implying an upregulation of defence mechanisms. These observations indicate that
selection of probiotic strains for salmonids requires careful experimentation not based
upon warm-blooded hosts. Strain-specific responses may also be linked to the
biochemical variability and complexity of bacterial cell wall components that elicit
differential responses in the host through pattern recognition receptor (PRR) interactions
(Bron, Van Baarlen and Kleerebezem 2012).
Another consideration is when to administer probiotic strains. When finfish
transition from the cold winter to the hot summer temperatures, their immune system is
part of the coping mechanism. The idea of administering probiotic bacteria or yeast prior
to summer when pathogen loads are higher, could prove to be an effective strategy to
prime the innate immune response without inducing excessive inflammation in the tissue.
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But how the probiotic organisms’ function inside fish swimming in cold versus warm
water needs to be investigated.
Studies employing transcriptomic approaches to survey the piscine response to
probiotic supplementation at the molecular level are beginning to unravel the mechanistic
links between host and microbe. For instance, supplementation of rainbow trout with a
strain of S. cerevisiae led to an upregulation of innate immune pathways in conjunction
with a mitigation of the stress response associated with high-density rearing systems
(Gonçalves, Valenzuela-Muñoz and Gallardo-Escárate 2017). This suggests that this S.
cerevisiae strain is able to overcome stress-induced immunosuppression and locally
stimulate the immune system to prime the organism for a more effective clearance of
pathogens. As such, future studies employing high-throughput methods to understand the
strain-specific molecular cascade of immunomodulation would do well to pave the path
towards enabling the leveraging of these properties for sustainable maximization of
aquaculture production.
Recent advances made with in vitro systems, such as the rainbow trout intestinal
epithelial cell line RTgutGC and gut-on-chip models, offer opportunities to investigate
host-microbe interactions at the molecular level (Kawano et al., 2011; Drieschner et al.,
2019; Pumputis et al., 2019; Wang et al., 2019). A gnotobiotic rainbow trout model may
also help with mechanistic investigation of these phenomena (Perez-Pascual et al. 2021).
It is hoped that such studies will aid in understanding probiotic effector molecules and
cognate host signaling pathways underlying the functional modulation of cellular
physiology in salmonids. Such models might provide a platform for rapid screening of
functional supplements. Though the translation of findings in the lab to the complex
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mucosal system in the field is not trivial, the knowledge gained represents a starting point
to address this key knowledge gap in the field.

Table 1-1. Summary of studies investigating the effects of probiotic supplementation in
the context of a disease challenge in salmonids.
Host
species
Rainbow
trout
(Oncorhynchus
mykiss)

Pathogen

Pathogen
dose

Strain(s)
designated as
‘probiotic’
Pseudomonas
fluorescens
AH2

Duration
of supp.

Vibrio
anguillarum
(90-11-287,
serotype O1)

105-106
CFU/ml,
bath
immersio
n

Aeromonas
salmonicida
SN1

1.8x107
CFU/mL,
bath
immersio
n
1.8x106
CFU/mL,
0.1mL IP
injected

Lacticaseibac
illus
rhamnosus
GG (ATCC
53103)
Bacillus
subtilis and B.
licheniformis

Lactococcus
garviae 2999 and
Streptococcus iniae
00-318

2x107
CFU/ml,
0.1mL IP
injected

Aeromonas
sobria GC2
(indigenous
isolate)

14 days

Aeromonas
salmonicida
Hooke and
Yersinia
ruckeri T1

A.s.:
2.4x107
cells/ml
Y.r..:
1.6x107
cells/ml,
0.1mL IP
injected

Carnobacteri
um
maltaromatic
um B26 and
Carnobacteri
um divergens
B33
(indigenous
isolates)

14 days

Yersinia
ruckeri O1

5 days
prior to
infection
(LT) and
during
infection
(ST)
15 days

16 weeks

Dose
(CFU/g
feed)
LT: 105
CFU/ml
ST: 107
CFU/ml,
bath
immersio
n
109 and
1012

4x104

108

107

Main findings

Ref.

• Inhibition of V.
anguillarum in vitro
• ↑ survival
(Gram et
al. 1999)

• ↑ survival
• No difference in
SGR
• ↑ survival
• No difference in
growth parameters
• No difference in
haematocrit, plasma
protein, or lymphocyte
counts
• ↑ survival
• ↓ morbidity
• Dosage optimum
• Live candidate
probiotic cells
necessary for benefits
• ↑ leukocyte count,
phagocytic activity,
and respiratory burst
• Viable in feed for up
to 3 weeks
• ↑ phagocytic activity,
SOD (B33 only), and
lysozyme activity
• No difference in antiprotease activity

(Nikoskelai
nen et al.
2001)

(Raida et
al. 2003)

(Brunt and
Austin
2005)

(Kim and
Austin
2006b)

26

Aeromonas
salmonicida
ABE1

IP: 102
CFU/mL
IM: 108
CFU/mL

Bacillus
subtilis AB1

Aeromonas
salmonicida
CLFP 501

1.7x106
CFU/mL;
0.1mL IP
injected

Lactococcus
lactis ssp.
lactis CLFP
100,
Leuconostoc
mesenteroides CLFP
196, and
Latilactobacillus sakei
CLFP 202
(indigenous
isolates)
Bacillus sp.
JB-1 and
Aeromonas
sobria GC2

Aeromonas
salmonicida,
Lactococcus
garvieae 2999,
Streptococcu
s iniae 00318, Vibrio
anguillarum
VIB1, Vibrio
ordalii VIB2
and Yersinia
ruckeri Pri10
Lactococcus
garviae
CLFP LG1

~2.5x107
CFU/mL,
0.1mL IP
injected

3.4 x 103
CFU/mL,
0.1mL IP
injected

Aeromonas
bestiarum
and
Ichthyophthi
rius multifilii

1x105
CFU/mL,
0.1mL ID
injected

Vibrio
anguillarum

3x105
CFU/mL,
0.1mL IP
injected

Vibrio
anguillarum

V.a.:
3x105
CFU/mL

14 days

14 days
prior to
infection

2 weeks

Leuconostoc
mesenteroides CLFP
196,
Lactiplantibacillus
plantarum
CLFP 238
Aeromonas
sobria GC2
or
Brochothrix
thermosphacta
BA211
Kocuria SM1
(indigenous
isolate)

4 weeks

Kocuria SM1
(indigenous
isolate)

107

106

2x108

107

• ↑ survival
• Dosage optimum
• ↑ erythrocyte count,
phagocytic activity,
respiratory burst,
lysozyme and protease
activity
• ↑ survival
• ↑ phagocytic activity
of HK leukocytes
• ↑ SOD production,
phagocytosis, and
complement activity
(ACH50) after 2
weeks

• In vitro inhibitory
activity to at least 1
pathogenic strain
• ↓ morbidity
• ↑ respiratory burst,
macrophage, and
protease activities
• Dosage optimum

• ↑ survival
• Supplemented strains
recoverable from
intestine

108
(CG2) or
1010
(BA211)

• ↑ survival
• ↑ phagocytic activity
(GC2)
• ↑ respiratory burst
activity (BA211)

Up to 4
weeks

108

2 weeks

108

• ↑ survival
• ↑ phagocytic activity
in HK, total serum
antiprotease, and
lysozyme activity
• ↑ survival

2 weeks

(NewajFyfzul et
al. 2007)

(Balcázar et
al. 2007c)

(Brunt,
NewajFyzul and
Austin
2007)

(Vendrell et
al. 2007)

(Pieters et
al. 2008)

(Sharifuzza
man and
Austin
2009)
(Sharifuzza
man and
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and Vibrio
ordalii

V.o.:
5x104
CFU/mL,
0.1mL IP
injected

Vibrio
anguillarum

3x105
CFU/mL,
0.1mL IP
injected

Kocuria SM1
(indigenous
isolate)

1.2x106
cells/mL,
0.1mL IP
injected

Enterococcus
casseliflavus
NC0209951
(indigenous
isolate)

Streptococcus
iniae ATCC
29178

Vagococcus
salmoninarum and
Lactococcus
garvieae

Vaccine
against
Yersinia
ruckeri
KC291153

V. s.:
1.8x108
CFU/fish
L.g.:
1.2x107
CFU/fish,
0.1mL IP
injected
Immersio
n vaccine

2 weeks;
trial up to
5 weeks
following
cessation
of
supplemen
tation
8 weeks

Fish isolates:
Lactobacillus
lactis spp.
Pediococcus
acidilactici
Latilactobacillus sakei

3 weeks

Lactiplantibacillus
plantarum
426951
(indigenous
isolate)

72 days

108

T1. 107
T2. 108
T3. 109

108

• ↑ cellular and
humoral immune
parameters
• ↑ in leukocytes,
erythrocytes, globulin,
albumin
• ↑ respiratory burst,
complement, and
lysozyme activities
• ↑ survival
• ↑ serum lysozyme
and respiratory burst
activities of blood
• ↑ serum peroxidase
and bacterial killing
activities
• ↑ growth
• ↑ survival
• ↑ neutrophil count at
week 4
• ↑ serum IgM and C3
levels at week 4 and 8
in all diet groups; ↑ in
total serum protein and
albumin in T3 at week
8
• ↑ respiratory burst
activity in T2 and T3
at week 8
• No change in
intestinal morphology
• In vitro inhibition of
the pathogen
• Dose-response
relationship
• In vitro inhibition of
the pathogen
• ↑ survival

Austin
2010a)

(Sharifuzza
man and
Austin
2010b)

(Safari et
al. 2016)

(Didinen et
al. 2018)

2x107

• ↑ serum total protein
and complement
activity in
supplemented +
vaccine group
• ↑ lysozyme activity
and growth
performance in
supplemented +
vaccine group

(Soltani et
al. 2019)
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Rainbow
trout
(Oncorhynchus
mykiss)
and
Atlantic
salmon
(Salmo
salar)
Brook
Charr
(Salvelinus
fontinalis)

A.
salmonicida
Hooke
V.
anguillarum
V72
V. ordalii
V453
Y. ruckeri
PR110
Aeromonas
salmonicida
subsp.
salmonicida

5x107
CFU/ml,
0.1mL IP
injected

Brown
trout
(Salmo
trutta)

Aeromonas
salmonicida
NCIMB1102

Infection
induced
by heat
stress
(opportun
istic
pathogen)

Only in
vitro
studies

Carnobacterium sp.
K1
(indigenous
isolate)

4 weeks

Pediococcus
acidilactici
MA 18/5M,
Peudomonas
fluorescens
ML11A,
Aeromonas
sobria TM18
Lactococcus
lactis CLFP
100 or
Leuc.
mesenteroides CLFP
196

16 weeks

4 weeks

5x107

2x105
CFU/mL
tank
water,
bath
immers.
106

• ↑ survival after 14
days
• Transient strains (not
recoverable after
cessation of
supplementation)

• In vitro inhibition of
the pathogen
• ↑ Fulton index
(growth) with
Pedicoccus
supplementation
• Modulation of innate
immune response
• ↑ survival
• Presence of both
strains in the fish
intestine
• ↑ phagocytic activity
in HK leukocytes
• ↓ pathogen load

(Robertson
et al. 2000)

(Gauthier et
al. 2019)

(Balcázar et
al. 2009)

LT = long-term; ST = short-term; IP = intraperitoneal; IM = intramuscular; ID = intradermal; SOD =
superoxide dismutase; RT = rainbow trout; HK = head kidney; dpi = days post-infection; GI =
gastrointestinal.

1.2.4 Pathogen inhibition
Microbe-microbe interactions play a vital role in the modulation of host fitness.
Evidence suggests an important role for probiotic-mediated reduction in pathogen
adherence to mucosal surfaces, limiting growth through nutrient exclusion, direct
antagonism through the secretion of antimicrobial molecules, or lowering the local pH
(Ringø et al., 2020; Figure 1-1). LAB isolated from healthy rainbow trout have been
shown to exhibit strain-specific inhibitory abilities against a panel of aquatic pathogens.
All isolates (namely Lactococcus lactis subsp. lactis CLFP 100, Lc. lactis subsp.
cremoris CLFP 102, L. curvatus CLFP 150, Leuc. mesenteroidetes CLFP 196, and L.
sakei CLFP 202) preferentially adhered to intestinal mucus and caused a substantial
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reduction in the adherence of A. salmonicida, C. piscicola, Lc. garviae, and Y. ruckeri to
intestinal mucus (Balcázar et al. 2007c). Interestingly, however, Leuc. mesenteroidetes
CLFP 196 induced a slight increase in the adherence of A. salmonicida to intestinal
mucus, from which the authors substantiate the argument that the investigation of strainspecific effects is needed to assess microbe-microbe interactions (Balcázar et al. 2007c).
A cautionary note should follow that the in vitro adhesion experiments may not be
indicative of what happens in vivo. Inhibition of pathogen growth has been reported in
several studies, some of which are summarized in Table 1.

Box 1. Disease challenge methods
Given that commensals, pathogens, and probiotic strains primarily act locally
in the gastrointestinal tract, the gut of fish has been considered the battleground for
these microbe-microbe interactions (Ringø et al. 2003). As such, disease challenge
methods that employ intraperitoneal infections circumvent the potential inhibition of
these pathogens by probiotics in the gut. Thus, the beneficial effects of probiotics in
fish against pathogens could be more powerful than such experimental evidence
currently indicates (Merrifield et al. 2010). Future studies must consider employing
challenge methods that aim to carefully mimic the real-life setting so as to obtain
biologically relevant insights and take into account the microbe-microbe interactions
that might be happening on mucosal surfaces, especially in the gut.

In an effort to better understand microbial dynamics in the context of the intestinal
mucosa, ex vivo approaches have been employed. For instance, P. acidilactici MA18/5M
outcompeted V. anguillarum in the rainbow trout gut and the probiotic was also able to
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populate the anterior intestine temporarily (Harper et al. 2011). Strains of L. delbrueckii
subsp. lactis and Carnobacterium divergens Lab01 have been found to exert a protective
effect against insults induced by A. salmonicida subsp. salmonicida on the intestine of
Atlantic salmon ex vivo (Salinas et al., 2008; Hartviksen et al., 2015). Further, C.
divergens was able to decrease the adherence of A. salmonicida to the intestinal mucosa
(Hartviksen et al. 2015). These approaches are supportive of an in vivo effect, but
mechanistic studies are needed to prove how they achieve this.

Figure 1-2. The salmonid intestinal mucosa as a portal of entry of pathogens into the
bloodstream. The fish intestinal microbiota exists on a spectrum, in which the healthy
state is characterized by homeostasis in the community and minimal damage to
intercellular tight junctions. When dysregulation occurs, pathogens proliferate in the
lumen and secrete virulence factors, which degrade the epithelial barrier and cause
inflammation. Pathogens can then translocate to the lamina propria and enter into the
circulation, thus causing haemorrhagic septicaemia and death.
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1.2.5 Bacteriocin production
Beneficial microbes can directly antagonize the growth of bacterial pathogens
through the secretion of bacteriocins, which are essentially peptides that exhibit
antimicrobial activity against specific targets (Dobson et al. 2012). In the complex milieu
of the gastrointestinal tract, bacteriocins play diverse roles that include microbial
signaling, colonization, as well as killing organisms (Fajardo and Martínez, 2008;
Dobson et al., 2012). Several studies have investigated salmonid-derived isolates that
produce bacteriocins and aid in biopreservation of fish products (Gatesoupe, 2007;
Desriac et al., 2010). Three strains of Carnobacterium spp. isolated from cold-smoked
Atlantic salmon appear to have bactericidal properties against Listeria monocytogenes
(Nilsson et al., 2002; Brillet et al., 2004). Sahnouni et al. (2016) isolated four strains of
fish gut-associated LAB (Loigolactobacillus coryniformis L.11, Limosilactobacillus
fermentum L.03, and Carnobacterium spp. Cb04 and Cb10) and demonstrated the
bacteriocin-mediated inhibition of a range of pathogenic microorganisms, including
Vibrio, Aeromonas, Salmonella, and Escherichia spp. Nevertheless, in vivo evidence
reporting bacteriocin-mediated pathogen inhibition remains scarce (Gatesoupe 2007). As
such, while bacteriocins appear to be a factor in modulating microbiota homeostasis in
the gut, other components, such as organic acids and hydrogen peroxide, may play a more
prominent role (Vázquez et al., 2005; Tomé et al., 2006).

1.2.6 Suppression of virulence expression
Bacteria use quorum sensing (QS) to communicate with each other through the
secretion of autoinducer molecules in a cell density-dependent manner (Suga and Smith,
2003; Defoirdt, 2014). This also plays an important role in the regulation of microbial
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phenotypes, including biofilm formation, virulence expression, swarming, and
bioluminescence (Waters and Bassler 2005). Acylated homoserine lactones (AHLs) are
key molecules involved in QS. These are produced by several aquaculture-relevant
pathogens, such as A. salmonicida, A. hydrophila, V. anguillarum, V. harveyi, V.
salmonicida, and Y. ruckeri (Kastbjerg et al., 2007; Defoirdt, 2014). Since bacterial
pathogenesis is to a degree regulated by QS, an anti-infective strategy could be devised to
employ quorum quenching (QQ), which disrupts the bacterial communication. Indeed,
several fish-associated Bacillus strains have been investigated for their QQ properties
against aquatic pathogens (Kuebutornye et al. 2020). For example, Bacillus cereus BPMBRG/1b and Bacillus sp. QSI-1 have been shown to degrade AHL molecules of A.
hydrophila, thus disrupting QS and preventing infection in prawns (Macrobrachium
rosenbergii), goldfish (Carassius auratus) and zebrafish, respectively (Chu et al., 2014;
Zhou et al., 2016; Wee et al., 2018). Delshad and colleagues (2018) identified five
rainbow trout-associated microbes that exhibit QQ properties against Y. ruckeri, the
etiological agent of enteric red mouth disease. While pathogen growth was unaffected,
biofilm formation, motility, and AHL production were significantly inhibited in vitro.
Furthermore, the strains conferred a survival advantage of up to 50% in a disease
challenge, albeit differences were substantial between QQ strains (Delshad et al. 2018).
These studies highlight the use of candidate probiotic strains for disease control in
aquaculture through the modulation of pathogen virulence.
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Box 2. Host-associated beneficial microbes
The selection of probiotic strains has tended to be based on species already
characterized. Since most work has been done on human strains, this has led to these
same species being applied to fish. Although the origin of species need not detract
from its successful application to a different host, autochthonous strains from fish are
worthy of exploration as probiotic candidates. Several isolates derived from aquatic
animals have been shown to inhibit pathogens, promote growth, and modulate
mucosal immunity in the host (Van Doan et al., 2020; Table 1-1). Normally, probiotic
strains do not colonize the host gut. It would be interesting to determine whether
autochthonous strains from fish can colonize the intestine and be better choices for
aquaculture applications. The indigenous microbes will likely have coevolved with
aquatic pathogens, making them more adaptable to preventing infection. Concerns
remain, however, regarding the safety and market-readiness of these emerging
beneficial microbes. Thus, all commercial probiotic strains must be proven to be safe.

1.4 Methods of probiotic encapsulation and delivery
To achieve health benefits in humans, it is generally believed that a minimum of
108-109 viable probiotic cells are required to reach the intestine (Hou et al. 2003; Oliveira
et al. 2009). Another report suggested that an efficient probiotic formulation should
contain a minimum viable cells number of 106 CFU/g by the end of shelf-life (NeffeSkocińska et al. 2018). However, the number per se is not the issue. The evidence of
benefit must come from tests in the host. Thus, if less or more viable organisms are
needed, then that is what should be delivered. To act as a substitute for prophylactic
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antibiotics in aquaculture and promote salmonid health, 106-108 probiotic CFU/ml per
tank or CFU/g have been used (Table 1). The main challenge is to maintain this viability
at time of use, which requires stringent documentation during their industrial production
and along the storage and handling stages.

Figure 1-3. Delivery vehicles of live microorganisms in aquaculture systems. Types
of microcapsules (A) and commonly used microencapsulation methods for probiotics (B).
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1.4.1 Probiotic delivery methods
The route of probiotic administration for aquatic animals has included application
directly into rearing water, supplementation of live food (Artemia and rotifers), inclusion
in pelleted feed, and use of oral gavage (Masoomi Dezfooli et al. 2019). It is important to
note, however, that probiotic delivery to the fish through water might reach untargeted
aquatic animals, which may raise safety concerns since the effect on these animals is
unknown. Having stated that, a detrimental disturbance of the aquatic body is unlikely
given the lack of pathogenic attributes of probiotic strains and the considerable inoculum
that would be needed.
Oral gavage and injection routes are labour-intensive and time-consuming
processes, which incur additional costs and stress to the animals. The use of probioticcoated pelleted feed would enable dosage control of the viable number of administered
organisms, thus preventing loss and untargeted delivery. As such, coated pelleted feeds
are a more suitable and economical probiotic delivery method to reach the fish intestine.
Importantly, incorporating the organisms in the feed has to be achieved without
compromising their viability in the nutrient formula and during exposure to the water.
Further research is required to optimize this process and monitor the enclosure to make
sure the less aggressive feeders still acquire the probiotic strains in adequate amounts.

1.4.2 Effect of acid, bile, and storage conditions on probiotics
One criterion for selecting a probiotic is the ability of the organism to survive in
the low gastric pH (1.0-3.5) and intestinal bile salt environment (Merrifield et al. 2010).
The gastric pH of rainbow trout before feeding is ~2.7 (Bucking and Wood 2009), which
is low enough to kill bacterial strains unless they have resistance traits or are in a delivery
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vehicle or coating that protects them. Many strains of Lactobacillus acidophilus and
Bifidobacterium spp. are unable to survive at low pH and bile salt-rich environment
(Shah et al. 1995). Even yoghurt-producing bacteria L. delbrueckii subsp. bulgaricus and
S. thermophilus often fail to reach the small intestine with robust viability (Desai 2008).
Similarly, proper storage conditions of probiotics in dry and cool environments are
required to ensure stability of the viable count. These issues have led to some sporeforming bacteria being used as probiotics, as they can retain stability in a range of
environmental conditions. However, verification that the strains come out of their spore
form and provide a benefit needs more documentation.

1.4.3 Encapsulation strategies and delivery systems
Encapsulation is a strategy that uses a shell or coating material to protect and
preserve the active ingredients (probiotics, in this case). The size and shape of the
encapsulated ingredient may vary depending on the coating material and technique used
(Figure 1-3 A). The concept is to protect the organisms during storage and passage
through the stomach and ensure controlled release of the strains in the small intestine or
colon (Berkland et al., 2004; Anal and Singh, 2007; Champagne and Fustier, 2007;
Wagdare et al., 2010). The use of capsules for fish presents its own challenges, such as
the small size of young salmon, exposure to lake or sea water, and the rate at which the
organisms need to be released inside the host. The controlled release of probiotics based
on pH or other physiological conditions of the intestinal segments may provide an
opportunity for the encapsulation material to site-specific release of the contents in the
gastrointestinal tract.
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There are a variety of encapsulation techniques available, which are generally
prepared by three methods viz. chemical, physico-chemical, and physico-mechanical
techniques (Figure 1-3 B). Often, these methods are combined. Among these, spraydrying is the most common, economical, and effective technique for production of food
ingredients, however it has not been widely used for the encapsulation of probiotics
(Chavarri et al., 2015). Freeze-drying is the preferred and least harmful drying method for
probiotics, but it is more costly relative to spray-drying (Chávez and Ledeboer 2007).
Innovative approaches that strive to maintain the viability of live active ingredients while
remaining economically feasible are of interest to the aquaculture industry.

1.4.4 Encapsulating materials for probiotics
Biomaterials are often used in capsule formation as they are biocompatible,
widely available, and have minimal to no effect on probiotic viability and host health
(Solanki et al. 2013). Biomaterials are defined as “natural or engineered synthetic
macromolecules, which can be used to establish interaction with biological systems for
therapeutic or diagnostic purposes”. The chemical structure and the conformation of the
monomer units provide specific functionality, such as cross-linking to form gels (Renard
and Reddy 2007). Over the past few decades, biopolymer alginate has been used
extensively for the encapsulation of probiotics (reviewed by Shori, 2017). Generally,
calcium alginate is suitable for encapsulation due to its simplicity, non-toxicity,
biocompatibility and low cost (Krasaekoopt, Bhandari and Deeth 2003). However,
alginate beads are sensitive to the acidic environment, an obvious flaw when placed into
gastric pH (Mortazavian et al. 2008). Furthermore, the impact of the alginate on the
intestinal microbiome remains to be shown. Hydrogels, such as alginate-chitosan,
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alginate-whey protein, alginate-pea protein, and alginate-gelatin are also used to
encapsulate probiotic strains (Kwiecien and Kwiecien, 2018).
Other biomaterials such as κ-carrageenan, gelatin, chitosan, whey proteins,
cellulose acetate phthalate, locust bean gum, and starches have also been explored (Anal
and Singh 2007; Shori 2017). In one study, strains of L. rhamnosus, B. longum, and L.
acidophilus entrapped in κ-carrageenan microcapsules showed higher acid and bile
tolerance (Ding and Shah 2009). Κ-carrageenan-based hydrogels have been successfully
used as delivery systems for lactobacilli, Streptococcus, and Bifidobacterium species
(Kwiecień and Kwiecień 2018). Xanthan-alginate, xanthan-alginate-chitosan, xanthanchitosan, xanthan–chitosan–xanthan, pectin, pectin–chitosan, pectin–whey protein,
pectin–rice bran extract have also been used (Kwiecień and Kwiecień 2018). Chitosan
has antimicrobial properties, hence it is not suitable for the encapsulation of probiotics
(Sonia and Sharma 2011). Interestingly, a carboxymethyl cellulose-chitosan hybrid
showed improved viability under simulated gastric conditions (Singh et al. 2017).
Among nanomaterials, cellulose nanocrystals (CNCs), starch nanoparticles, and
silica nanoparticles, in combination with other materials, are being used for encapsulation
of probiotics. Microcapsules consisting of alginate-CNC-lecithin showed greater viability
of L. rhamnosus ATCC 9595 after passing through simulated gastric juice (Huq et al.
2017). Resistant starch, glucomannan, shellac, cellulose acetate phthalate (CAP), and κcarrageenan are promising materials for encapsulation of probiotics when used with
alginate (Cui et al. 2018). Probiotic strains can also be encapsulated using a colloidal
system that comprises a dispersed phase in a liquid medium. There are different colloidal
systems, such as oil-in-water (O/W), water-in-oil (W/O), water-in-water (W/W), and
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water-in-oil-water (W/O/W) being investigated for the maintenance of strain viability
(Vemmer and Patel, 2013; Picone et al., 2017; El Kadri et al., 2018; Singh et al., 2018).
The hydrophobic, hydrophilic, and amphiphilic nature of these nanomaterials
determines how they are used to incorporate the organisms into the capsule. The
nanocapsules are made using nanoparticles that are formed into particles that are actually
micrometres in size in order to accommodate the microorganisms. The material is
generally polymeric and selected based on diffusion, degradation, pH or temperature of
the target site. The lack of availability of low-cost, generally regarded as safe (GRAS)
nanomaterials that have minimal interference with probiotic strains, have limited their
widespread application. To address these limitations, lipids are being considered as
carrier for lipophilic pharmaceuticals, which are also described as solid lipid nano
particles (SLNPs). The vehicle promotes the rapid absorption of the pharmaceuticals
through lipolysis in the small intestine (Souto and Müller 2010). Further, nanostructured
lipid carriers (NLCs) with lipids in the liquid form offer more versatility due to their
broad physico-chemical properties compared to SLNs.
The delivery of probiotics using nano-gels and poly-electrolyte complexes have
also shown promise. Nanogels are prepared using various methods of copolymerization
of hydrophilic or water-soluble monomers in the presence of difunctional or
multifunctional cross-linkers (Oh, Bencherif and Matyjaszewski 2009). Polyelectrolyte
complex-mediated delivery involves electrostatic forces between biopolymers, which
then contribute to the coating of probiotic-loaded microcapsules (Borges and Mano,
2014; Anselmo et al., 2016; Singh et al., 2017). Recently, Luan et al. (2018) developed a
cellulose-based composite macrogel using cellulose fiber/cellulose nanofiber (CCNM)
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for the delivery of probiotic strains to the intestine. Research is needed to delineate the
effect of these substances on the host microbiota and to determine if all the nanoparticles
are excreted.
Clearly, there is room for more research and development of methods to produce
cost-effective, eco-friendly materials that deliver probiotic organisms to the fish gut to
ensure that these strains confer measurable benefits on the host.

1.5 Hypothesis and objectives
Given that the intestinal mucosa plays a central role in host homeostasis and that
host-microbe interactions can profoundly impact host health, it was hypothesized that
microbial modulation of tight junctions and immune function may lead to improvements
in survival and growth in Chinook salmon. To address this hypothesis, two
complementary objectives were devised. First, an in vitro model of the salmonid gut was
developed to study the mechanism of host-microbe interactions. The gold standard
salmonid intestinal epithelial line, RTgutGC, was employed, and several coincubation
experiments were performed to determine the molecular and physiological response of
the cells to exposure with candidate fish probiotics and/or the marine pathogen, V.
anguillarum. Second, to further validate the findings in the organism under study, an in
vivo experiment was carried out in Chinook salmon, in which the animals were fed with
the candidate beneficial microbes and then injected with live V. anguillarum. The
purpose of the in vivo study was to determine the organismal response to the lactic acid
bacteria and investigate whether the beneficial strains could mitigate the deleterious
effects of the pathogenic infection. The goal of this research is to investigate the use of
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candidate fish probiotics as an alternative strategy to reduce losses related to infectious
diseases in the aquaculture sector.

1.6 Summary and prospects of fish probiotics
Host-microbe interactions at the intestinal mucosal interface display pleiotropic
links with organismal health and are directly correlated with productivity in aquaculture
animals. The rich microbial environment within and around salmonids cannot be
overlooked as a key factor in the health and wellness of fish. Research over the past two
decades, including novel modeling systems, has begun to unravel the key mechanisms
and pathways through which probiotic microbes can be applied to this milieu and
contribute health benefits. The key is to carefully select strains, study their properties, and
administer them in an optimal formulation. Then, prove they confer a benefit in field
trials complemented by high-resolution, high-throughput, and multi-omics analyses. To
progress further, increased attention should be given to the metagenome and the
functional state of the microbes to restore and maintain health. In order for probiotic
strains to modulate the immune response effectively, studies are needed to better
understand the direct interaction of bacterial cell wall components and metabolites with
host receptors. The importance of delivery vehicles that ensure the viability and activity
of the living therapeutics cannot be overstated. This is a critical area of research that has
enormous potential for the aquaculture industry, particularly given the transient nature of
the fish microbiome.
There is a degree of urgency to reduce losses in the aquaculture sector. The
increasing demand of fish for human consumption is offset by an inability to control
long-standing pathogens at a time when water pollution and competition for natural
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resources are mounting. This is a juncture where bringing together expertise in
microbiology, fish research, genetics, behavioural science, chemical engineering, and
synthetic biology is essential to maximize production sustainably.
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Chapter 2
2. Investigation of host-microbe interactions in an in
vitro model of the salmonid gut
2.1 Abstract
Host-microbe interactions are central to fish health and aquaculture’s
productivity. Given the immense burden of infectious diseases in the industry, novel
microbial management strategies are imperative to ensure the sustainable intensification
of production. The use of tissue culture models to investigate the mechanism underlying
microbial modulation of fish health has not yet been explored in the context of probiotic
microorganisms. The purpose of the present study was to assess the applicability of the
salmonid intestinal epithelial cell line RTgutGC for the investigation of host-microbe
interactions and to elucidate the mechanism through which the candidate probiotic strains
modulate gut barrier function and protect from pathogenic organisms, such as Vibrio
anguillarum. The expression of several key tight junction (TJ) and immune molecules
was assessed, along with changes in transepithelial electrical resistance (TEER) given by
the cell monolayer. While the candidate probiotic strains did not significantly upregulate
tight junction molecules, pre-treatment with the microbes protected against pathogeninduced insults to the barrier. The expression of occludin was significantly induced by V.
anguillarum, and this molecule might be implicated in the pathogenesis of this organism.
Pre-treatment with lactic acid bacteria did not substantially alter the expression of TJs or
immune molecules. The RTgutGC model provided a new means to identify candidate
probiotic strains for salmonid aquaculture.
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2.2 Introduction
Aquaculture is steadily growing and will need to intensify its production to meet
growing global demands (FAO 2020). As such, greater attention has been given to factors
that can help promote animal health in farmed fish, particularly salmonids, which
constitute the most economically important family of finfish. Infectious diseases pose a
huge threat to the industry (Groff and LaPatra 2000). The fish gut is thought to be a
primary site for pathogen attachment, proliferation, and entry into the bloodstream
(Olsson et al. 1996). The intestine is a key site for digestion and nutrient absorption,
immune modulation, osmoregulation, and acting as a barrier against pathobionts
(Dawood 2021). Unfortunately, pathogens can infect the host through damaging the
intestinal lining. For example, Vibrio anguillarum is a common but deadly aquatic
pathogen that afflicts farmed fish worldwide, causing substantial financial losses
(Lafferty et al. 2015). This Gram-negative aquatic halophilic bacterium uses an arsenal of
virulence factors to infect its host (Frans et al. 2011). The current proposed mechanism of
infection suggests that the pathogen colonizes the skin and gills, but it is not until it
reaches the intestine that it expresses its array of virulence factors that can cause injury to
the epithelial lining (Denkin and Nelson 1999; Weber, Chen and Milton 2010). The
damage caused thus opens the ‘door’ to bacterial translocation from the intestinal lumen
to the lamina propria, and from there, to portal blood, therefore causing haemorrhagic
septicaemia and death (Cisar and Fryer 1969). Although this is the proposed mode of
entry based on the current understanding of V. anguillarum’s pathogenesis, mechanistic
studies seeking to characterize the host response at the intestinal epithelial interface are
lacking, as are studies on how non-pathogens might interfere with this process.
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The current disease containment strategies employed by the industry are either
inadequate (ie. antibiotics contribute to antimicrobial resistance; Watts et al. 2017) or
insufficient (ie. vaccines offer limited protection; Dixon 2012; Figueroa et al. 2020).
Given these constraints, interest has grown in the use of eco-friendly microbial
therapeutics, such as probiotic supplementation, to mitigate and prevent infections in
farmed fish (Ringø et al. 2020).
Several studies using different probiotic strains have reported health benefits in
salmonids such as stress mitigation, reduction in mortality to pathogens, improvements in
growth parameters, immune modulation, and homeostasis in the commensal microbiota
(Merrifield et al. 2010; Fečkaninová et al. 2017; Gonçalves, Valenzuela-Muñoz and
Gallardo-Escárate 2017; Al-Hisnawi et al. 2019; Gupta et al. 2019). The source of these
microbes can differ, from human-derived strains to indigenous isolates from finfish
species. The vast majority of candidate probiotics belong to lactic acid bacteria (LAB)
genera, which encompass lactobacilli, as well as Bacillus, Pediococcus, and
Carnobacterium spp (Ringø et al. 2018).
The selection of strains for use in salmonid aquaculture applications is often based
on research in terrestrial host species, especially mammals. However, there are clearly
substantial differences in the physiology of terrestrial and aquatic hosts, thus making
generalizations challenging. An additional issue is the retention of strain viability from
production to the field, and for successful delivery to the fish. Given the size of the losses
and the increased demand for farmed fish, there is an urgent need to identify beneficial
microorganisms that can effectively contribute to fish health.
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The use of models can provide a high-throughput screening system to identify
promising fish probiotic candidates. In humans, the Caco-2 colon carcinoma cell line is
regarded as the gold standard intestinal epithelial cell model of the small intestine
(Hubatsch, Ragnarsson and Artursson 2007). Recent reports on a salmonid intestinal
epithelial cell line derived from rainbow trout (Oncorhynchus mykiss), RTgutGC, have
established the usefulness of this cell line as a model for functional studies on fish feed
development based on gut barrier function and immune competence (Kawano et al. 2011;
Langan et al. 2017; Minghetti et al. 2017; Wang et al. 2019). Furthermore, by employing
semipermeable membrane supports (Transwell®), it is possible to recapitulate the
intestinal environment in vitro and conduct studies on the permeability and integrity of
the cell monolayer (Hubatsch, Ragnarsson and Artursson 2007).
The objectives of the present study were to i) establish the RTgutGC model; ii)
investigate the effect of candidate probiotic strains on barrier function and the expression
of tight junction and immune molecules; iii) determine the extent to which V.
anguillarum disrupts barrier function; and iv) assess whether probiotic strains can protect
the epithelial monolayer integrity against pathogen-induced insults.
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2.3 Materials and methods
2.3.1 Tissue culture maintenance
The rainbow trout intestinal epithelial cell line RTgutGC was generously provided
by Dr. Brian Dixon’s lab at the University of Waterloo. RTgutGC cells were cultured in
Leibovitz’s 15 media (HyClone, catalogue number: SH30525.01), supplemented with
10% heat-inactivated fetal bovine serum (HI-FBS; Life Technologies, catalogue number:
26140079) and incubated in plates or flasks sealed with Parafilm (Bemis, ACAPM999) at
22ºC and atmospheric conditions. The medium was replaced every 3-4 days and cells
were passaged when ≥80% confluent in a 1:2 to 1:4 subcultivation ratio, depending on
the downstream experimental application. The RTgutGC cells in T75 flasks (Corning,
catalogue number: 353136) were trypsinized by aspirating the medium with a glass
Pasteur pipette (Fisher Scientific, catalogue number: 13-678-20A) connected to a vacuum
line. Cells were washed with 4mL sterile PBS at room temperature, and residual buffer
was aspirated in like manner. Four mL of trypsin (0.05% w/v; Thermo Fisher Scientific,
catalogue number: 25200056) was then added and incubated for 10 minutes at room
temperature on a flask vortex to facilitate detachment. Cells were monitored periodically
using a Nikon inverted microscope to ensure detachment from the plastic. Upon
detachment, 8mL of complete culture medium (L-15 + 10% FBS) was added to quench
the trypsin protease activity. The suspension was then vigorously pipetted to break up
clumps of cells, before transfer of the cells to a 15mL sterile conical tube from which a
sample was taken for viable counting using a trypan blue (0.04%; Thermo Fisher
Scientific, catalogue number: C10312) exclusion assay and the automated Countess cell
counter (Invitrogen, catalogue number: C10281) prior to seeding into the cell culture
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dishes. Medium renewal was performed 24-48h following trypsinization and seeding into
new culture dishes to remove residual trypsin.

2.3.2 Bacterial strains and culture conditions
Bacterial strains were generously provided by Seed Health, Inc. and Lallemand
Animal Nutrition, Inc. Lacticaseibacillus rhamnosus GG, Limosilactobacillus rhamnosus
LR06, Limosilactobacillus reuteri LRE2, Limosilactobacillus reuteri 830,
Limosilactobacillus reuteri RC-14, Limosilactobacillus rhamnosus GR-1, and
Pediococcus acidilactici 18MA/5M were routinely cultured anaerobically at 37ºC in
Mann, Rogosa, and Sharpe (MRS) medium (BD Difco, catalog number: DF0881-17-5).
Bifidobacterium breve BR03 was routinely cultured anaerobically using a GasPak (BD
Difco, catalogue number: 261205) at 37ºC in brain heart infusion-supplemented (BHI-S)
culture medium (BD Difco, catalog number: DF0418-17-7), supplemented with yeast
extract (5g/L), resazurin solution (25mg/100mL; add 4mL/L), L-cysteine•HCl (0.5g/L),
and vitamin K1 (0.2mL/L). The Leuconostoc mesenteroides 8293 and Leuconostoc
mesenteroides 1506 were routinely cultured anaerobically in MRS medium at room
temperature (23ºC) for 48h.
Vibrio anguillarum serotype O1 was kindly provided by Dr. Brian Dixon’s
laboratory at the University of Waterloo. This strain was originally obtained from Pacific
Biological Station (PBS) in Nanaimo, BC from Dr. Simon Jones, during an outbreak in
winter Steelhead trout (Oncorhynchus mykiss irideus) in Little Campbell River, BC. The
strain was routinely cultured in tryptic soy broth or agar (TSB/TSA; BD Difco, catalogue
number: DF0370-17-3) supplemented with 2% (w/v) sodium chloride. Heat-killed V.
anguillarum was prepared by transferring 1mL of a liquid culture of the bacterium (TSB
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+ 2% NaCl (w/v) inoculated with a single colony and incubated for 24h aerobically at
23ºC in an orbital shaker at 250 rpm) to a 1.7mL tube, which was then centrifuged at
3000 rpm for 3 minutes. The supernatant was discarded and the bacterial pellet was
resuspended in 1mL of sterile PBS and incubated at 100ºC for 30 minutes in a bead bath
(Bennoit and Craig 2020). Then, 100µl of the heat-killed suspension was plated in TSA +
2% NaCl (w/v) to ensure sterility.

2.3.3 Coculture experiments
RTgutGC cells were cultured in 6- or 12-well plates (BD Falcon, catalogue
number: 353046) for at least 3 weeks prior to the experiments to ensure that the cells
established the brush border membrane and tight junction complexes. Frozen stocks of
LAB and V. anguillarum were streaked onto agar plates of the appropriate medium and
incubated for 24h. Single colonies were then re-streaked and incubated for another 24h.
Fresh single colonies were used to inoculate 3mL of the appropriate growth medium and
cultures were incubated for 48h. Assuming that the concentration per area of cells at
confluency is approximately 1.3 x 105 cells/cm2, the LAB were diluted to a final
multiplicity of bacteria (MOB) of 1:100 gut cells to bacteria, while V. anguillarum was
diluted to a final concentration of 2:1 MOB. Heat-killed V. anguillarum was diluted in
like manner. The bacterial suspensions were mixed in the cell culture growth medium and
the spent cell culture medium was aspirated using a sterile glass Pasteur pipette connected
to a vacuum line. The bacteria were then added to the RTgutGC cells and incubated for
various durations. Cells were then harvested at specific timepoints by aspirating the
culture medium and adding 1 or 0.5 mL (for 6- or 12-well plates, respectively) of TRIzol
reagent (Invitrogen; catalogue number: 15596018), and removed by vigorously pipetting
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the RTgutGC cell lysate, which was then transferred to a 1.7mL tube and stored at 4ºC
until further processing.

2.3.4 RNA extraction and cDNA synthesis
To prepare RNA for subsequent gene expression analyses, 0.3 volumes of
chloroform per 1 volume of TRIzol were added to the RTgutGC cell lysates. Samples
were vortexed for 15 seconds, incubated at room temperature for 10 minutes, then
centrifuged at 16,000 rpm for 15 minutes at 4ºC. The aqueous layer was collected (being
careful not to come near the layer interface) and transferred to a new 1.7mL tube. To
improve RNA quality, 0.3 volumes of chloroform per 1 volume of the aqueous layer were
again added, and this step was repeated. Samples were kept on ice henceforward.
To the new aqueous fractions, 0.7 volumes of 100% isopropanol per 1 volume of
sample were added, vortexed briefly, and incubated at room temperature for 5 minutes.
Samples were then centrifuged at 16,000 rpm for 15 minutes at 4ºC. The supernatant was
discarded, and residual isopropanol was removed with a pipette (being careful to not
disturb the RNA pellet). Then, 1mL of 70% ethanol in nuclease-free water (Invitrogen,
catalogue number: 4387936) was added and samples were centrifuged at 16,000 rpm for
15 minutes at 4ºC. The ethanol was decanted, and this step was repeated to improve RNA
quality and remove contaminants. The residual ethanol was carefully removed, and
pellets were air-dried for 15 to 20 minutes. The RNA was then resuspended in 30µl of
warm (56ºC) nuclease-free water and quantified using a NanoDrop spectrophotometer.
The RNA concentration was consistently between 100-500ng/µl, depending on the size of
well used for the experiments. The cDNA was synthesized from 1µg of the freshly
isolated RNA using a High-Capacity cDNA Reverse Transcription Kit, following
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manufacturer’s instructions (Applied Biosystems, catalogue number: 4368814), for a total
volume of 40µl per reaction. Remaining RNA was stored at -80ºC.

2.3.5 Real-time quantitative PCR analysis
Reverse-transcribed cDNA was diluted 10x and used in qPCR reactions with
Power SYBR Green Kit (Thermo Fisher Scientific, catalogue number: A46112). The
primers used in this study are summarized in Table 2-1. For analyses of gene expression,
the gene CX6C1 was used as the reference because it was identified to be the most stable
reference gene of those tested. The PBS vehicle control groups were used as the
endogenous control in all qPCR experiments. Each qPCR reaction had a total volume of
10µl (performed in three technical replicates). Reactions consisted of 4.58µl of diluted
cDNA, 0.42µl of primers (forward and reverse primer mix; 14.4µM), and 5µl of Power
SYBR Green 2x Master Mix. The PCR reaction conditions were 50ºC for 2 minutes, then
95ºC for 10 minutes, followed by 40 cycles of 95ºC for 15s, then 60ºC for 1 minute. The
melt curve stage consisted of 95ºC for 15s, then 60ºC for 1 minute and 95ºC for 15s. The
qPCR was performed on a QuantStudio5 Real-Time PCR System (Thermo Fisher
Scientific) and analyzed using the associated cloud-based Design and Analysis software
(Thermo Fisher Scientific; version 2.5.1). Gene expression (2–∆∆Ct) was calculated using
fold change. PCR efficiencies were assessed using the LinRegPCR software version
2016.1 and determined to be above 1.80 Table 2-1.
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Table 2-1. Summary of RT-qPCR primers used in this study.
Gene
name
CX6C1
IL-1b
IL-6
IL-8
IL-10
IL-17a
TGFb
TNFa
JAM-1a
Occludin
Claudin 3
Claudin
12
Ecadherin
ZO-1

Accession
number
FR904651
.1
NM_0011
23582
NM_0011
24657.1
NM_0011
40710
NM_0012
45099.1
GW57423
3
EU08221
1
AJ277604
.2
XM_0215
64368.2
XM_0216
01275.2
XM_0215
87920
XM_0216
21241
XM_0215
85993.2
XM_0369
63739.1

Sequence (5’-3’)
F: GCCTGCAATGCGAGGACTCC
R: TTCCTTGGTTCTGTTACGCCGTAC
F: GCTGGAGAGTGCTGTGGAAGA
R: TGCTTCCCTCCTGCTCGTAG
F: GTTCTGGGTGAGGTGTCTA
R: GGTGTCAACCAGGAAGTTAC
F: ATTGAGACGGAAAGCAGACG
R: CGCTGACATCCAGACAAATCT
F: CCATCAGAGACTACTACGAGGC
R: TCTGTGTTCTGTTGTTCATGGC
F: TGGTTGTGTGCTGTGTGTCTATGC
R: TTTCCCTCTGATTCCTCTGTGGG
F: AGTTGCCTTGTGATTGTGGGA
R: CTCTTCAGTAGTGGTTTGTCG
F: GTGATGCTGAGTCCGAAAT
R: GTCTCAGTCCACAGTTTGTC
F: TGAGGATGGAAGTCCGCAAC
R: GTACCACAGTCCGAAGCACA
F: GACAGTGAGTTCCCCACCAT
R: AGCTCTCCCTGCAGGTCCTT
F: AGGCAACGACGCTACATCAA
R: GAAACCCAAGCAATGCGTCA
F: ATCATCGCCTTCATCTCCGT
R: TAGCAGCCAGAGTAGCCATC
F: ACTACGACGAGGAGGGAGGT
R: TGGAGCGATGTCATTACGGA
F: CAAAGCCAGTGTATGCCCAG
R: CAGCTTCATACTCGGCCTGA

Amplicon
size (bp)

Reference

114

This study

73
93
136
165
136
191
97

Wang et al.
2020
Schug et al.
2019
Wang et al.
2020
Wang et al.
2020
Wang et al.
2020
Wang et al.
2020
(Semple et al.
2018)

98

This study

101

This study

112

Wang et al.
2019

161

This study

107

This study

119

Wang et al.
2020

2.3.6 Transepithelial electrical resistance
To determine the change in epithelial electrical resistance given by the effect of
different treatments on the cell monolayer, a TEER experiment was carried out. Prior to
seeding cells onto the Corning Transwell polyester membrane cell culture inserts (6.5 mm
and 0.4µm pore size; catalog number CLS3470), baseline resistance was determined to be
107/0.33cm2 using a STX2 chopstick electrode connected to a voltmeter. RTgutGC cells
(passage number 20-30) were grown in T75 flasks, trypsinized when maximally (>90%)
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confluent, and cell counts were performed using the trypan blue (0.04%; Thermo Fisher
Scientific, catalogue number: C10312) exclusion assay and the automated Countess cell
counter (Invitrogen, catalogue number: C10281) prior to seeding into the cell culture
dishes. The cells were seeded on semipermeable Transwell membrane supports (Corning
Costar Transwell, Millipore Sigma, catalogue number: CLS3470) at a density of
approximately 2.6 x 105 cells/cm2 or a final number of about 8,58 x 104 cells per insert
(cell growth aera of 0.33 cm2). The cells were cultured for at least 3 weeks prior to the
experiment to ensure that they established the brush border membrane and tight junction
complexes. To the apical and basolateral compartments 100µl or 500µl, respectively, of
L-15 media supplemented with 10% FBS were added, and the medium was replaced
every 4-5 days. Periodic inspection of the cell monolayers was carried out using a Nikon
inverted light microscope.
Bacterial cultures were prepared as outlined in section 2.3.3 and bacteriacontaining cell culture growth medium was added to the RTgutGC cells and incubated for
24h. At the end of the incubation time, culture medium was carefully removed so not to
disturb the cell monolayer and the transwell inserts were transferred to a new 24-well
plate containing sterile PBS on the basolateral compartment. To the apical compartment,
100µl of PBS were added. Cell monolayers were likewise washed two more times, 100µl
of PBS was added to the apical compartment and 500µl to the base of the electrode, and
measurements were recorded using a cup electrode collected to a voltmeter. The baseline
reading (membrane only) was subtracted from the measurements and the resistance per
cm2 was determined. Statistical analyses were performed on the resistance values per
area.
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2.3.7 Statistical analyses
All statistical analyses were done using GraphPad Prism software version 7.0a.
Nonparametric data were statistically compared with a one-way ANOVA (KruskalWallis) and Dunn’s multiple comparisons test. Experiments with two factors were
compared with a two-way ANOVA and Tukey’s multiple comparisons test.
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2.4 Results
2.4.1 Effect of coincubation with LAB on the expression of tight
junction and immune molecules in RTgutGC cells
After a 24h incubation period, L. reuteri LRE2 exhibited a nonsignificant increase
in the expression of zo-1 and claudin-3 (Figure 2-1 B, C), whereas L. reuteri 830 and L.
rhamnosus GR1 with L. reuteri RC14 caused a downregulation in all TJ molecules tested
(Figure2-1 B-D). L. rhamnosus GG elicited a modest increase in claudin-3 expression,
but this was not observed with zo-1 or claudin-12 (Figure 2-1).
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Figure 2-1. Effect of LAB exposure on the expression of key TJ molecules in
rainbow trout gut cells. RTgutGC cells were incubated with lactobacilli (MOB 1:100;
~7.5x108 CFU/mL) for 24h and gene expression was measured using RT-qPCR. All data
are expressed as mean values ± SD (n=3). Transcript abundance was normalized to bActin as per MIQE guidelines. Statistical significance was determined by a nonparametric one-way ANOVA (Kruskal-Wallis) and Dunn’s multiple comparisons test.
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To further examine whether other LAB could promote gut barrier integrity in the
established RTgutGC in vitro model, a 48h endpoint coincubation experiment was
performed using differentiated RTgutGC cells (Pumputis et al. 2018). The LAB strains
were chosen based on reports suggesting their barrier-promoting properties (Del Piano et
al. 2010), extensive use in aquaculture settings (Al-Hisnawi et al. 2019), as well as
indigenous Leuconostoc isolates obtained from wild Chinook salmon guts. Namely, the
strains selected were Bifidobacterium breve BR03, Lacticaseibacillus rhamnosus LR06,
Limosilactobacillus reuteri LRE2, Pediococcus acidilactici 18MA/5M, Leuconostoc
mesenteroides 8293, and Leuconostoc mesenteroides 1506. The exogenous LAB did not
cause a significant change in the expression of the tight junction genes assessed (claudin3, zo-1, and claudin-12). However, exposure to the indigenous Leuconostoc spp. resulted
in a significant decrease in the expression of the TJ molecules examined (Figure 2-2 BD). The exogenous LAB strains also did not induce changes in expression of key
proinflammatory cytokines, whereas the Leuconostoc strains did (Figure 2-2 E).
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Figure 2-2. Effect of LAB coincubation on the expression of key TJ molecules in

rainbow trout gut cells. RTgutGC cells were incubated with LAB for 48h (MOB 1:100;

~7.5x108 CFU/mL) and gene expression was measured using RT-qPCR. All data are

expressed as mean values ± SD (n=3). Transcript abundance was normalized to CX6C1
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as per MIQE guidelines. Statistical significance was determined by a non-parametric oneway ANOVA (Kruskal-Wallis) and Dunn’s multiple comparisons test.

2.4.2 Changes in transepithelial electrical resistance in response to
LAB and V. anguillarum coincubation
To investigate whether the candidate probiotics and/or V. anguillarum could
modulate the integrity of the epithelial layer, a transepithelial electrical resistance (TEER)
assay was performed (Srinivasan et al. 2015). Differentiated RTgutGC cells cultured on
semipermeable Transwell polyester membrane supports (pore size 0.4µm) were exposed
to suspensions of the LAB strains (MOB 1:100; ~4x106 CFU/mL) or V. anguillarum
(MOB 2:1; ~2x104 CFU/mL) in L-15 cell culture media for 24h (Figure 2-3 A). V.
anguillarum, but not the LAB strains, caused a significant decrease in resistance relative
to the vehicle control (Figure 2-3 B).
To determine whether pre-treatment with the LAB strains could protect the cell
monolayer against the pathogen-induced damage to the intercellular tight junctions, slight
modifications to the aforementioned experimental design were performed. Briefly, the
same LAB strains were grown and added to the apical compartment of the membrane
inserts in like manner for 48h. Then, V. anguillarum (MOB 2:1; ~2x104 CFU/mL) was
added for 24h and TEER measurements were taken at the end of the incubation period
(Figure 2-3 A). There were no statistically significant differences in resistance in either
of the LAB-pretreated groups, despite the addition of the pathogen. However, a
statistically significant decrease in resistance (P = 0.0265) was observed in the group
incubated with V. anguillarum only (Figure 2-3 C).
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Figure 2-3. Transepithelial electrical resistance in response to exposure to candidate
probiotic strains or V. anguillarum. RTgutGC cells were seeded on Transwell
semipermeable transmembrane supports and bacteria were added to the apical
compartment for 24h. The vehicle group was not exposed to bacteria at any time, and the
V. anguillarum group was incubated only with the bacterium for the latter 24h of the
experiment. TEER was determined based on the resistance given by the monolayer per
area, normalized to the blank measurement. Statistical significance was determined by a
non-parametric one-way ANOVA (Kruskal-Wallis) and Dunn’s multiple comparisons
test.

2.4.3 Effect of exposure to Vibrio anguillarum on the expression of
tight junction and immune molecules
To characterize the response of RTgutGC cells to live or heat-killed (HK) V.
anguillarum, a time-course coincubation experiment was carried out. Samples were
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collected at 0, 3, 6, and 24h. Of the TJ-related molecules assessed, there was a significant
downregulation of e-cadherin and JAM-1a, but not occludin, which had a puzzling
upregulation by 24h (Figure 2-4 B-D). Of the cytokines assessed, all exhibited a timedependent upregulation, which was statistically significant at the 24h timepoint relative to
the 0h control group (Figure 2-4 E-G). In the case of il-8, but not il-17a or tgf-β, the
upregulation was observed in cells exposed to both live and HK bacteria. In an
independent replicate of this experiment, a similar time-dependent response was
observed, in which there was a significant upregulation of il-1β, il-8, and tnfα at the 24h
timepoint for groups exposed to live bacteria (data not shown).
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Figure 2-4. Time-course analysis of salmonid intestinal cells to live or heat-killed V.
anguillarum. RTgutGC cells were exposed to either live or HK bacteria (2:1 MOB at the
time of inoculation) and gene expression was measured using RT-qPCR. All data are
expressed as mean values ± SD (n=3). Transcript abundance was normalized to CX6C1
as per MIQE guidelines. Statistical significance was determined by a non-parametric twoway ANOVA and Dunn’s multiple comparisons test. (**** P<0.0001, *** P=0.0001, *
P=0.0493)

2.4.4 Effect of pre-treatment with LAB and exposure to V. anguillarum
on the expression of immune and tight junction molecules
To examine the potential use of LAB as a disease prevention strategy by
stimulating immunity and gut barrier function, a time-course coincubation experiment
was executed. Briefly, differentiated RTgutGC cells were pre-treated with LAB strains
for 48h and then exposed to V. anguillarum. Samples were taken at 0h, 3h, 6h, and 12h
after infection with the pathogen and the relative expression of key TJ and immune
molecules was assessed through RT-qPCR (Figure 2-5 A). The LAB strains selected
were B. breve BR03, L. rhamnosus LR06, L. reuteri LRE2, L. rhamnosus GG, L.
rhamnosus GR1, P. acidilactici 18MA/5M, and the indigenous isolate L. mesenteroides
1506.
The expression of zo-1 was significantly increased at the 12h timepoint in cells
pre-treated with L. reuteri LRE2 and indigenous isolate L. mesenteroides 1506 relative to
the baseline control (T=0h pre-treatment control group). Additionally, zo-1 was
significantly upregulated at the 12h timepoint relative to the expression level at 6h in
groups pre-treated with L. rhamnosus GG, P. acidilactici 18MA/5M, and L.
mesenteroides 1506 (Figure 2-5 B). The expression of claudin-3 was significantly
increased at the 6h timepoint relative to levels at 0h in groups pre-treated with B. breve
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BR03, L rhamnosus LR06, L. reuteri LRE2, and L. rhamnosus GR1, as well as in the
control group. There was also a significant decrease in expression between the 6h and
12h timepoints in the control and L. reuteri LRE2 groups (Figure 2-5 C). There were no
statistically significant differences in the expression of e-cadherin at between treatment
groups or timepoints (Figure 2-5 D). The expression of jam-1a was significantly
increased between the 3h and 6h timepoints in the L. rhamnosus LR06 group, but
subsequently decreased by 12h. There was also a significant downregulation of the
molecule between 0 and 12h in the P. acidilactici 18MA/5M group (Figure 2-5 E).
The expression of the pro-inflammatory cytokines IL-8 and IL-17a was also
assessed. There was an extremely significant upregulation of il-8 in all groups at the 12h
timepoint relative to the baseline control (Figure 2-6 A). The expression of il-17a was
upregulated at the 3h timepoint in the L. rhamnosus LR06 and L. rhamnosus GG groups
relative to the baseline control and to the levels at 0h (Figure 2-6 B).
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Figure 2-6. Effect of pre-treatment with select LAB strains and V. anguillarum on
the expression of proinflammatory cytokines. RTgutGC intestinal epithelial cells were
incubated with LAB for 48h (MOB 1:100; ~7.5x108 CFU/mL), then infected with V.
anguillarum (2:1 MOB at the time of inoculation) and samples were collected at 0, 3, 6,
and 12h post-infection. The control group was not pretreated with LAB at any time and
was only exposed to V. anguillarum for the latter 12h of the experiment. Gene expression
was assessed using RT-qPCR. All data are expressed as mean values ± SD (n=3).
Transcript abundance was normalized to CX6C1 as per MIQE guidelines. Statistical
significance was determined by a two-way ANOVA and Tukey’s multiple comparisons
test.
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2.5 Discussion
Host-microbe interactions are central to fish health and aquaculture’s profitability.
However, studies to date are predominantly disease-centric and lack the resolution
necessary for elucidating mechanistic links between microbes (beneficial or otherwise)
and their aquatic hosts. The pressing need for novel sustainable solutions for mitigating
infections makes the use of models appealing as a rapid and cost-effective tool for
screening candidate beneficial microbes and for investigating underlying mechanisms.
This knowledge is useful because it can inform in vivo studies and can provide actionable
insights for targeted solutions. The purpose of the present study was to assess the
suitability of the salmonid intestinal epithelial cell line RTgutGC as a tool for
investigating host-microbe interactions and to evaluate the potential benefits of candidate
fish probiotic strains in vitro.
The effects of select strains of LAB and the fish pathogen V. anguillarum were
assessed in RTgutGC cells grown on conventional culture plates and Transwell
semipermeable membranes. Co-incubation experiments were performed to study the
effects of the bacteria on the host transcriptional response of immune and tight junction
molecules. Additionally, transepithelial electrical resistance (TEER) was performed to
evaluate the integrity and barrier function of the cells.
This study showed that L. reuteri 830, known for its probiotic activity in humans,
could significantly decrease in the expression of zo-1 and claudin-3 in fish intestinal
cells, while L. rhamnosus GR1/L. reuteri RC14 could decrease the expression of claudin12 after 24h (Figure 2-1). This indicates that the origin of the lactobacilli may not be
critical for their activity to be conferred, at least in relation to the human and fish
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intestinal epithelium. A comparative genomic analysis of L. reuteri strains suggested that
human strains have undergone reductive evolution whereas rodent isolates possess a large
and adaptable pan-genome (Frese et al. 2011). No fish isolates of L. reuteri were
examined, but core effects on intestinal epithelia may be conserved across isolates
suggesting an important role played by lactobacilli in barrier function irrespective of the
host. This implies that use of human probiotic strains still has merit in applications to
salmonids.
To further examine the effect of additional exogenous and endogenous LAB
strains on the immune and gut barrier properties of the cells, a 48h endpoint coincubation
experiment was performed. Interestingly, there were properties unique to the fish isolates.
Only the L. mesenteroides 1506 and 8293 strains caused significant differences in the
expression of barrier molecules zo-1, claudin-3, and claudin-12, which were decreased
relative to the control group. The expression of the proinflammatory cytokines il-8, il-6,
and il-1b were significantly upregulated by the L. mesenteroides strains (Figure 2-2).
It is not clear why Leuconostoc alone would influence ZO-1 and claudin-3, since
these are important in scaffolding and transmembrane TJ proteins, respectively
(Tipsmark and Madsen 2012). Claudin-12 is expressed in the salmonid gill and skin
(Chasiotis et al. 2012; Gauberg, Kolosov and Kelly 2017). But its role in the gut remains
unknown (Sundell and Sundh 2012). Leuconostoc are human gut constituents, often
obtained through dairy consumption (Study et al. 2020), but their properties do not
appear to be particularly suitable to human applications (Argyri et al. 2013).
The upregulation of proinflammatory cytokines IL-6, IL-8, and IL-1β elicited
exclusively by the indigenous Leuconostoc isolates is suggestive of a response to a
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bacterial threat. This observation begs the question of whether these strains are suitable as
probiotic candidates for salmonids or if these are potentially harmful. The latter scenario
is unlikely, as Leuconostoc have not been associated with pathogenic outbreaks in fish.
However, the data herein presented indicates that these strains might not be the most
appropriate for supplementation, as the excessive immune activation can in turn be
detrimental to the barrier integrity and contribute to infection by pathobionts (Suzuki,
Yoshinaga and Tanabe 2011). Although some strains with beneficial properties in fish
have reportedly elicited an upregulation of proinflammatory markers in key mucosal and
immune organs, it is thought that this response is part of an orchestrated effect that
ultimately leads to homeostasis. Whether this is the case for the LAB strains tested here is
unclear, but future studies would do well to elucidate the mechanism underlying the
physiological benefits observed in aquatic species.
Barrier formation and integrity was assessed by TEER measurements, which were
in line with levels reported previously (Geppert, Sigg and Schirmer 2016; Minghetti et al.
2017; Wang et al. 2019). A significant decrease in resistance was observed in cells
exposed only to V. anguillarum for 24h (Figure 2-3 B), but pre-treatment with select
LAB strains for 48h prior to exposure to the pathogen mitigated these effects (Figure 2-3
C). These results are supportive of using LAB to protect the epithelial barrier against
pathogen-induced insults. Improvements in barrier function has been reportedly
associated with increased levels of related tight junction gene (cldn3 and cdh1) and
protein (Claudin-3) expression (Geppert, Sigg and Schirmer 2016; Minghetti et al. 2017;
Wang et al. 2019). Although the data in the present study is apparently in contrast with
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these findings, the effect observed is modest and incubation with LAB protected against
pathogen-induced damage but did not increase resistance after a 48h incubation period.
Since the expression of barrier-forming TJ molecules was unchanged, an increase
in resistance was not expected (Figure 2-1 B-D; Figure 2-2 B-D). The significant
decrease in resistance given by V. anguillarum is expected since the arsenal of virulence
factors expressed by this bacterium are believed to degrade the epithelial barrier to gain
access to the circulation (Frans et al. 2011). Further investigation of this phenomenon
through orthogonal methods (such as Lucifer Yellow dye translocation studies) would be
useful to ensure that the changes observed are physiologically relevant.
It has been proposed that V. anguillarum induces changes in the barrier function
by producing proteases and toxins to invade the lamina propria (Olsson et al. 1996).
Following a time-course coincubation experiment with live or heat-killed V. anguillarum,
it was found that e-cadherin and jam-1a were significantly downregulated by 24h postinfection in the live group relative to the heat killed group and the baseline control.
Interestingly, the expression of occludin was significantly increased in the live group at
the 24h timepoint (Figure 2-4 D). These data seem to suggest that V. anguillarum not
only impairs the barrier integrity, but the pathogen can also inhibit the expression of key
barrier-forming TJ molecules.
The role of occludin in fish is not well understood, but studies in other organisms
suggest that this protein is not only an integral component of tight junctions in various
tissues, but that it can also participate in tight junction remodeling in response to
cytokines (Van Itallie et al. 2010; Sawada 2013). High levels of proinflammatory
cytokines, such as TNF-α and IFN-γ, promote the endocytosis of occludin in the tight
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junction complexes, which coincides with increases in tight junction permeability (Yu
and Turner 2008). Moreover, cytokine-induced changes in TEER and flux are directly
proportional to occludin levels (Van Itallie et al. 2010). Paradoxically, the results in the
present study appear to be at odds with the observations previously reported, in which the
increased expression of occludin given by live V. anguillarum (Figure 2-4 D) exposure is
associated with a decrease in resistance (Figure 2-3 B, C). Further validation of this
observation is required, but these results potentially indicate that occludin might
potentiate the inflammatory response and exacerbate the damage to the epithelial lining
during infection in the salmonid gut (Van Itallie et al. 2010).
Tight junctions have complex regulatory networks that dynamically respond to
physiological stimuli (Sawada 2013). Therefore, post-transcriptional and posttranslational modifications can profoundly impact the biological function of the junctions.
Analyses that consider not only the molecular phenomena impacting barrier function, but
also the dynamic nature of these intercellular junctions, would be instrumental in
understanding how the gut epithelium responds to threats and activates immune defence
mechanisms.
There was a robust upregulation of il-8 and tgfb assessed by the 24h timepoint for
cells incubated with live V. anguillarum. Notably, there was also a time-dependent
increase in the expression of il-8 for both live and heat-killed groups, and these levels
were significantly higher by 24h. These results indicate that IL-17a and TGFβ are
involved in the response to secreted virulence factors, whereas IL-8 might be more
implicated in the response to cell wall components such as lipopolysaccharides (LPS).
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The upregulation of results are in line with the proposed mechanism of IL-8 induction
given by LPS in other organisms (Yan et al. 2017).
The two human isolates, L. rhamnosus LR06 and L. rhamnosus GG upregulated
expression of il-17a (Figure 2-6 B). In mammals, IL-17a is produced by a subset of T
helper cells that induce the production of antimicrobial peptides, among other
proinflammatory molecules (Iwakura et al. 2008). Host stimulation by LPS,
peptidoglycans, and other antigens through pattern recognition receptors enables antigenpresenting cells to activate naïve T cells that mediate the adaptive immune response to
the threat (Iwakura et al. 2008). Increased expression of IL-17a is also related to
increased permeability of the blood brain barrier and small intestinal epithelial barrier
(Rahman et al. 2018). In the context of the present study, pathogen-induced upregulation
of IL-17a might enhance the damage to the epithelial barrier and thus contribute to the
establishment of the infection. Therefore, it is puzzling that two probiotic strains also
upregulated il-17a in intestinal epithelial cells.
Pretreatment with LAB has been associated with protection from pathogeninduced injury to the intestinal epithelium in vitro (Karimi et al. 2018). The data
presented here suggest that the LAB strains tested have a mild effect in preventing
pathogen-induced changes in the expression of key barrier proteins. Slight differences in
trends of expression of zo-1 were observed in groups pre-treated with L. reuteri LRE2, L.
rhamnosus GG, P. acidiliactici 18MA/5M, and L. mesenteroides 1506 relative to the pretreatment control group (ie. Vibrio only), indicating that these strains can potentially
induce the expression of this key tight junction molecule in spite of the presence of the
pathogen. The trends in claudin-3 expression were different to the control only in the L.
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mesenteroides 1506 group. Further studies to explore L. mesenteroides and its
exopolysaccharide’s ability to induce intestinal IgA or the ratio of CD4+ T-cells/CD8+ T
cells would have been interesting (Matsuzaki et al. 2015) but were outside the scope of
this thesis.
There were no noteworthy differences in the trends of expression of the
transmembrane glycoprotein e-cadherin relative to the control group, but a 50-60% nonsignificant reduction in the expression of this molecule was observed by the 12h
timepoint in all groups. E-cadherin is important for barrier formation in the gut, though
its role in immune mediation in fish remains largely unclear. The glycoprotein functions
as the receptor for induced phagocytosis and internalization of Listeria monocytogenes
into Caco-2 epithelial cells (Mengaud et al. 1996). The human pathogen Vibrio cholerae
produces a toxin that impairs recycling of cadherins to cell-cell junctions, thereby
disrupting the barrier function (Ireton 2018). Viruses can also affect the gut lining. In
Atlantic salmon, single nucleotide polymorphisms (SNPs) in an epithelial cadherin gene
were associated with resistance to infectious pancreatic necrosis virus (IPNV), suggesting
that cadherin can be targeted by bacterial and viral threats in the process of establishing
an infection (Moen et al. 2015). These interactions happen at the protein level, which
would likely not be reflected by changes in transcript abundance of this molecule.
Moreover, there were minor differences in trends in the expression of jam-1a relative to
the control and a similar downregulation of the expression levels was observed by the
12h timepoint.
The composition of tight junction complexes exhibit tissue-specific properties
(Gauberg, Kolosov and Kelly 2017). The knowledge of the physiological function and
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mapping of the expression of TJ protein isoforms is predominantly obtained from studies
in terrestrial organisms. It is, therefore, plausible that the target TJ molecules assessed in
the present studies have diverged evolutionarily and now exert biological functions
distinct from that in mammals. For example, claudin-3 is a vital barrier-forming molecule
present in tight junction complexes in the distal intestine (Feng et al. 2018). However, in
finfish, claudin-3b has been found to be highly expressed in the kidney, but not the
intestine, during saline adaptation in Atlantic salmon (Tipsmark and Madsen 2012). In
RTgutGC cells, claudin-3 primarily localizes to the cell-cell interfaces, indicating that it
likely plays a role in barrier formation. Likewise ZO-1, which was found around the cell
boundaries as continuous ribbons, possibly adjacent to claudin-3 (Pumputis et al. 2019),
which supports the use of the RTgutGC model.
The expression of il-8 was highly increased by the 12h timepoint, indicating that
the LAB strains tested were unable to dampen the excessive immune activation caused by
V. anguillarum that can lead to epithelial injury and further contribute to the infection.
The trends in the expression of il-17a show an upregulation of this molecule by the 3h
timepoint in groups pre-treated with B. breve BR03 and L. rhamnosus GG, although there
was considerable variability between biological replicates in the latter.
Overall, the human LAB strains tested here had properties potentially suitable for
application to salmonids, but these did not translate to significant protection of gut barrier
proteins. As such, these strains might be ill-suited to thrive in and promote host health in
distantly related and physiologically distinct organisms. The use of endogenous strains
showed more promising results, but safety assessments would be required given the
propensity to increase responses normally deemed to be associated with inflammation
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(Van Doan et al. 2020). The in vitro coculture system was a powerful and cost-effective
tool for the investigation of host-microbe interactions. The advent of the Transwell
system physiologically mimics the intestinal epithelial environment, in which the apical
and basolateral compartments recapitulate the intestinal lumen and portal blood,
respectively (Hubatsch, Ragnarsson and Artursson 2007).
The present study is the first of its kind to employ a tissue culture of the salmonid
intestine for investigating host-microbe interactions and to evaluate the potential of LAB
strains as candidate fish probiotics offsetting pathogen insults to the epithelial barrier.
The RTgutGC model system provides a high-throughput tool to identify suitable
probiotic strains worthy of further testing in live salmonids as long as the delivery vehicle
allows the organisms to become metabolically active during intestinal transit.
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Chapter 3
3. Chinook salmon field study: Investigating the
effects of probiotic supplementation in the context of a
pathogenic infection with Vibrio anguillarum
3.1 Abstract
Aquaculture is the fastest-growing sector in the livestock industry, and it has
become a critical contributor to the global food supply. However, the high incidence of
infectious diseases threatens productivity and causes financial instability in the industry.
Current management strategies consist of antibiotics, but efforts are being made to
explore the use of beneficial bacteria as an eco-friendly alternative. This study aimed at
investigating the effects of lactic acid bacteria (LAB) supplementation on the survival,
growth, and expression of key tight junction and immune molecules in the hindgut tissue
of Chinook salmon (Oncorhynchus tshawytscha) over the course of a disease challenge
with Vibrio anguillarum – a common but deadly aquatic pathogen. In total, 1800 fish
from five families were evenly allotted into six dietary treatments in a four-week
supplementation trial. The dietary treatments included a basal diet (control), a sodium
alginate vehicle control, and diets containing 1 x 108 CFU/g feed of the beneficial
microbes: Limosilactobacillus reuteri LRE2, Limosilactobacillus reuteri 830,
Lacticaseibacillus rhamnosus GR1 and Limosilactobacillus reuteri RC14, and
Pediococcus acidilactici 18MA/5M. Supplementation was started two weeks prior to
infection and was maintained over the course of the challenge. A total of 1x104 CFU/fish
of V. anguillarum was injected intraperitoneally and samples were collected on days 0, 1,
3, 7, and 14 post-infection. Weight, length, and tissue were obtained on five occasions
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and mortality was recorded daily. No negative effects in growth or survival were
observed prior to or during infection in either of the LAB-supplemented or control
groups. Gene expression analysis of the intestine on days 0, 3, 7, and 14 post-infection
revealed no significant change in the expression of tight junction molecules zo-1, jam-1a,
ocldn, ecadh, marveld2, cldn15, cldn28b, muc2, or vil1. Likewise, the expression of
immune markers il8, il10, il17a, tgfb, and myd88 were unchanged. Consequently, this
field trial did not provide evidence to support the use of these strains to promote growth,
disease resistance, or to modulate gut barrier function and intestinal mucosal immunity in
Chinook salmon challenged with V. angullarum. Alternative strains or delivery systems
or infecting the fish orally may still be worth testing, along with use of specific families
of fish, before concluding there is no role for these strains in fish management.

3.2 Introduction
Fueled by growing global demands of high-quality alternative protein sources,
aquaculture has become the fastest-growing sector in the livestock industry and its
productivity has far surpassed that of hatcheries (Martin 2017; FAO 2020). The Food and
Agriculture Organization (FAO) of the United Nations forecasts that an additional of at
least 40 million tonnes of fish protein will be needed to meet demands by the end of the
decade (FAO 2020). Concerted efforts have focused on the sustainable intensification of
production; however, the high incidence of infectious diseases threatens to jeopardize the
projected productivity goals (Lafferty et al. 2015). The substantial financial losses and
instability caused by these diseases has fueled an interest in effective and eco-friendly
solutions to tackle this challenge. In contrast to antibiotics, which enrich for antimicrobial
resistant organisms (He et al. 2017), and vaccines, which are largely ineffective in fish
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(Dixon 2012), probiotics have been investigated as an eco-friendly alternative (Langlois
et al. 2021).
Probiotics are defined as ‘live microorganisms that, when administered in
adequate amounts, confer a health benefit on the host’ (Hill et al. 2014). In some fish
species, probiotic supplementation has been associated with a better immune
performance, survival to pathogenic challenges, improved nutrient assimilation, and
growth (Langlois et al. 2021). Although the precise mechanism of action is unknown,
studies in other terrestrial and aquatic species seem to indicate that probiotics have
primarily two modes of action: modulation of the host response (direct) and indirect
modulation of the microbial community towards a state that promotes host health
(indirect) (Merrifield et al. 2010).
It is possible that the immune modulation is mediated by components in the cell
wall or metabolites that directly interact with the host (Bron, Van Baarlen and
Kleerebezem 2012). The survival to pathogenic challenges might be due to direct
antagonism with the pathogen or indirect modulation of the host fitness and immune
response (Ringø et al. 2018; Doan, Soltani and Ringø 2021). The improved nutrient
assimilation and growth might be due to the metabolism of otherwise indigestible
nutrients facilitated by the beneficial microbes (Sealey et al. 2009). These concepts hold
merit based on research in other systems and the investigation of the mechanism of action
of these microbes is invaluable in order to devise targeted approaches to promote fish
health.
The intestinal epithelium is the most prominent mucosal interface for host- and
microbe-microbe interactions in terms of microbial richness and abundance, as well as an
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extensive surface area for microbial contact with the host. The gut plays a vital role not
only in nutrient absorption and osmoregulation, but it is also a key immune organ
(Lazado and Caipang 2014). In fact, differences in immune competence between finfish
have been attributed to the ability to prevent pathogen attachment and proliferation in the
gut (Palaksha et al. 2008; Rajan et al. 2011; Gao et al. 2016). As such, strategies that
promote optimal gut health locally can also have substantial systemic benefits for the
host.
At the core of the intestinal mucosa is a single layer of epithelial cells and their
intercellular junctions (ie. tight junctions - TJ, gap junctions, and adherens juctions) that
enable the selectively permeable entry of luminal contents into the lamina propria. A
breach in this barrier can allow access of pathogens and other harmful compounds that
thus trigger infection and inflammation in the host (Bron et al. 2017). Although the
mechanism is unknown, studies in terrestrial organisms indicate that certain probiotic
strains can promote gut barrier function by upregulating the expression of TJ molecules
(Wang et al. 2018). This phenomenon has not previously been investigated in fish, but
the concept warrants attention, as the identification of a microbial-based strategy to
bolster fish immunity, enhance growth, and prevent infections through the modulation of
gut barrier health would be ground-breaking for the field.
Several classes of microbes have been proposed to benefit finfish, but the most
prominent group are lactic acid bacteria (LAB), which includes lactobacilli and members
of the Lactococcus, Leuconostoc, Enterococcus Streptococcus, Pediococcus,
Carnobacterium, and Weisella genera (Ringø et al. 2018). These LAB are common
residents of the finfish gut microbiota and some fish-associated strains have been shown

95

to promote host health (Ringø et al. 2018). However, research to date has been slow to
determine a high-throughput framework for identifying and characterizing novel fishassociated beneficial microbes, and in North America, there is no fish-derived probiotic
product available for large-scale use. As such, preparations containing exogenous strains
of LAB have been used in aquaculture settings with promising outcomes (Hoseinifar et
al. 2018).
Research in mammalian systems indicates that certain probiotic strains can
promote intestinal barrier integrity, which has been linked with the attenuation of
gastrointestinal disorders (Ukena et al. 2007; Patel et al. 2012; Wang et al. 2018). The
selected strains used in the present field trial were Limosilactobacillus reuteri LRE2,
Limosilactobacillus reuteri 830, Lacticaseibacillus rhamnosus GR1 and
Limosilactobacillus reuteri RC14, and Pediococcus acidilactici 18MA/5M. The rationale
for the selection of these candidate probiotics is based on the genetic similarities between
L. reuteri 830 and LRE2 as well as benefits in reported in other organisms (Mogna et al.
2014). Furthermore, L. rhamnosus GR1 and L. reuteri RC14 were selected as this
combination of strains has shown several health benefits in humans through interactions
at mucosal surfaces (Reid 2020; Cunningham et al. 2021). Numerous reports in the
literature have investigated P. acidilactici 18MA/5M for its health-promoting effects in
several salmonid species (Vasanth et al. 2015; Jaramillo-Torres et al. 2019).
Vibriosis, caused by the Gram-negative bacterium Vibrio anguillarum, is one of
the most prevalent bacterial diseases in aquaculture and incurs substantial losses to the
industry (Lafferty et al. 2015). This organism is a halophilic aquatic bacterium that
infects over 50 finfish and shellfish species worldwide. This pathogen is equipped with
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an arsenal of virulence factors, that include a siderophore-mediated iron acquisition
system, hemolysins, lipopolysaccharides and exopolysaccharides, toxins, secreted
proteases, and a polar flagellum that aids in motility (Frans et al. 2011). The pathogen
infects the host by entering the bloodstream primarily through the gut and gills (Grisez et
al. 1996; Olsson et al. 1996, 1998; O’Toole et al. 1999), and the fish quickly succumb to
haemorrhagic septicaemia (Grisez et al. 1996). The mortality of infected Chinook salmon
can reach up to 50% (Ching et al. 2010). In terms of disease control strategies, there have
been several commercially-available vaccines developed against V. anguillarum
consisting of inactivated whole cells or live attenuated bacteria (Frans et al. 2011).
Although these products do offer some degree of protection against the pathogen
(Angelidis, Karagiannis and Crump 2006), not even the best vaccines can completely
prevent the occurrence of disease (Austin and Austin 2007), which creates the need for
more effective antimicrobial strategies.
Salmonids are the most economically important class of farmed finfish in the
aquaculture world trade (FAO 2020). Although the farming of Atlantic salmon (Salmo
salar) dominates the market, the farming of indigenous species is preferred on the West
coast due to concerns of exogenous farmed escapees disrupting the native ecological
niche (Noakes, Beamish and Kent 2000). The farming of Chinook salmon (Oncorhynchus
tshawytscha) is favoured due to this species large size and high market value.
Additionally, indigenous farmed escapees could potentially mate with the wild
population, thereby reducing the biodiversity and decreasing the genetic variability of the
population (McGinnity et al. 2003). The use of sterile triploid salmon effectively
circumvents this issue, with the added benefit that triploid fish do not mature sexually,
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thus preventing losses in flesh quality (Pandian 1998; Benfey 2001). Triploids, however,
are more susceptible to infectious diseases (Ching et al. 2010) and exhibited 10-30%
greater mortality compared to diploid siblings in a bacterial disease challenge (Ching et
al. 2010; Semple et al., unpublished). Thus, improvements are needed to mitigate deficits
in immune function in triploid fish.
For the current study, it was hypothesised that improving intestinal barrier
function can reduce losses in aquaculture, given that nutrient adsorption, immunity, and
prevention of infection occur at this interface. The objective was to examine the
mechanisms through which certain probiotic bacteria can promote health in the context of
a live bacterial infection with Vibrio anguillarum in triploid Chinook salmon.
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3.3 Materials and methods
3.3.1 Spawning and animal husbandry
Chinook salmon (Oncorhynchus tshawytscha) were bred and reared at Yellow
Island Aquaculture Ltd. (YIAL), a Chinook salmon farm that follows organic standards
and has both freshwater hatchery and saltwater netpen facilities. The farm has been in
operation since 1985 and is located on Quadra Island, British Columbia, Canada (latitude:
N 50° 7' 59.124"; longitude: W 125° 19' 51.834"). To generate crosses, milt and eggs
were collected from inbred production fish and the quality of the gametes was monitored
to ensure a high level of fertilization. Fertilized eggs were then placed in a hydraulic
pressure system to induce triploidization (Johnson et al. 2004). The embryos were then
reared in vertical-stack incubation trays supplied with flow-through untreated spring
water (temperature was between 7–9ºC). Hatching took place approximately 10 weeks
post-fertilization. Alevins were then transferred to 160L rearing barrels supplied with
flow-through spring water at 1.0L/minute. The water temperature was approximately 8ºC
(temperature range 7–10ºC) and the dissolved O2 saturation was regularly monitored and
maintained at above 80%. Tanks received light from 7am to 5pm daily to maintain
normal circadian rhythms. The fish density was between 50-150 per barrel, and each
barrel contained individuals of a single family during the growth phase.

3.3.2 Fish diets
The animals were fed ad libitum two to three times a day with a fishmeal diet
(Taplow Feeds, FirstMate Animal Nutrition; Supplementary table 3-1) during the
growth phase. Probiotic supplementation was initiated 14 days prior to infection and
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animals received the LAB until the end of the disease trial, for a total of 4 weeks of
supplementation. Briefly, the probiotic-containing diets were prepared by adding the
lyophilized probiotics (Table 3-1) to 10mL of a sodium alginate solution (0.001% (w/w)
sodium alginate powder (Millipore Sigma, catalogue number: W201502) in tap water).
Next, 100g of fish feed were added to the suspension, and finally 10mL of a 100mM
CaCl2 (Thermo Fisher Scientific, catalogue number: C614500) solution were added to the
mix. The probiotic feed preparations were stored at 4ºC for no more than 72h.
Table 3-1. Amounts of lyophilized probiotic to be added to the fish feed for a total of 1 x
108 CFU/g feed.
Organism name
L. reuteri SD-LRE2-IT
L. reuteri SD-RD830-FR
L. reuteri RC14 &
L. rhamnosus GR1
Pediococcus
acidilactici MA18/5M

Supplier
Probiotical/SeedLabs
N/a
RepHresh-ProB

CFU/g
1 x 1011
4.94 x1010
1 x 109/cap

BioPowerPA/Lallemand
animal nutrition

1 x 1010

Amount/100g feed
100mg
200 mg
10 caps
1g

3.3.3 PIT tagging
To be able to track individual fish over the course of the experiment, passive
integrated transponder (PIT) identification tags were used. Fish were collected from their
respective barrels and anesthetized using a clove oil bath (ThermoFisher, catalogue
number: 10459550). Sedated individuals were then swiftly injected with a PIT tag
intramuscularly, positioned caudal to the tip of the pectoral fin. Weight was then
recorded, and fish were placed in an aerated recovery bucket for approximately 5 minutes
to ensure that the injection and/or the clove oil bath were not lethal to the animals.
Following recovery, the fish were transferred to flow-through freshwater tanks at a flow
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rate of 1.0L/minute. The water temperature was between 7–10ºC and the dissolved O2
saturation was regularly monitored and maintained at above 80%.

3.3.4 Bacterial cultures
Vibrio anguillarum serotype O1 was generously provided by Dr. Brian Dixon’s
laboratory at the University of Waterloo. The V. anguillarum strain was originally
obtained from Pacific Biological Station (PBS) in Nanaimo, BC from Dr. Simon Jones.
This strain was isolated from a diseased winter steelhead trout (Oncorhynchus mykiss
irideus) obtained from Little Campbell River, BC. V. anguillarum was routinely cultured
in tryptic soy broth or agar (TSB/TSA) supplemented with 2% (w/v) sodium chloride.
For the infection challenge, a streak plate was prepared and incubated at room
temperature (23˚C) for 48h. A single colony was used to inoculate 5mL of TSB+2%
NaCl, which was then incubated for 24h at room temperature on an orbital shaker at
approximately 220 rpm. The starter culture was then used to inoculate a total volume of
50mL of TSB+2%NaCl, which was incubated in like manner. Dilutions were then
prepared in sterile PBS to a final concentration of 1x105 CFU/mL. The bacterial
suspension was immediately used and maintained at 4˚C until injection.

3.3.5 Disease trial design
Triploid Chinook salmon of five distinct crosses (more specifically, 60 fish per
family for a total of 300 fish per treatment, split evenly into in 2 technical replicate tanks)
were fed with either the candidate probiotics (Table 3-1; 1x108 CFU/g), regular feed with
sodium alginate coating (vehicle control), or regular feed, for a total of four weeks. The
trial was conducted in flow-through freshwater tanks at a flow rate of 1.0L/minute.
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Outflow water underwent UV sterilization (493.5 mJ/cm2) to ensure the biocontainment
of the pathogen. The water temperature ranged from 7–10ºC and the dissolved O2
saturation was regularly monitored and maintained at above 80%. Mortality was recorded
daily, and samples were collected on days 0, 1, 3, 7, and 14 by overdosing fish in a clove
oil bath. Full-body weight and length were then recorded, and PIT tags were removed
through a lateral incision to access the site of insertion. Whole fish were stored long-term
in 50mL tubes (Sarstedt, catalogue number: 50809218) filled with RNAlater (Thermo
Fisher Scientific, catalogue number: AM7021) at -20ºC until further sample processing.

3.3.6 Infection with live V. anguillarum
After 2 weeks of supplementation with the diets, fish were collected from their
respective tanks and anesthetized in a clove oil bath. Although the pathogen infects via
the intestine and gills, for practical reasons, all animals received an intraperitoneal 100µl
injection of live V. anguillarum in sterile PBS for a total infectious dose of approximately
1x104 CFU/fish. This dose has been previously tested to induce approximately 50%
mortality in Chinook salmon, with deaths initiating at around day 4-5 (Semple et al.,
unpublished). Animals were then placed in an aerated recovery bucket for approximately
5 minutes to ensure that the injection and/or the clove oil bath were not lethal to the fish.
Following recovery, the fish were returned to their designated tanks.

3.3.8 Growth parameters
o Weight gain (WG): WDN – Fam. avg. WD0, where N is the sampling day
o Percent weight gain (%WG): 100*(WD0- WD-14)/ WD-14
o Specific growth rate (SGR): 100*[ln(WDN) – ln(Fam. avg. WD0)]/N
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3.3.9 RNA extraction and cDNA synthesis
Hindguts were dissected from all individuals and stored in an aliquot of the
RNAlater solution. RNA was extracted by removing the tissue from the RNAlater
solution with sterile forceps and blotting out excess solution by pressing the hindgut
tissue between two sheets of sterile laboratory tissue paper (Kimberly-Clark Professional
Kimwipes, catalogue number: KC34120). RNA was extracted using the RNeasy Plus
Mini Kit (Qiagen, catalogue number: 74134). Briefly, hindguts were placed in a screwcap 2mL micro tubes (Thermo Fisher Scientific, catalogue number: 3469NK) containing
2mm and 0.5mm zirconia beads and the supplied homogenizing buffer. Samples were
homogenized using a BioSpec3110BX Mini Beadbeater 1 (Fisher Scientific, catalogue
number: NC0251414) beating five times for 90s at 7,000rpm. Tubes were then
centrifuged for 30s at ≥8,000 rpm at room temperature to pellet debris and transferred to
the spin column, following manufacturer’s instructions. RNA was eluted in 30µl of
elution buffer and quantified using a NanoDrop spectrophotometer. cDNA was
synthesized from 500ng of the freshly isolated RNA using a High-Capacity cDNA
Reverse Transcription Kit, following manufacturer’s instructions (Thermo Fisher,
catalogue number: 4368814), for a total volume of 20µl per reaction. Remaining RNA
was stored at -80ºC.

3.3.10 Real-time quantitative PCR analysis
Reverse-transcribed cDNA was diluted 10x and used in qPCR reactions with
PowerTrack SYBR Green Kit (Thermo Fisher, catalogue number: A46113). The primers
used in this study are summarized in Table 3-2. For analyses of gene expression, the gene
RPS20 was used as the reference because it was identified to be the most stable reference
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gene of those tested (Supplementary Figure 3-1). Each qPCR reaction had a total
volume of 10µl (performed in three technical replicates). Reactions consisted of 4.58µl of
diluted cDNA, 0.42µl of primers (forward and reverse primer mix; 14.4µM), and 5µl of
PowerTracker SYBR Green 2x Master Mix. PCR reaction conditions were 50ºC for 2
minutes, then 95ºC for 10 minutes, followed by 40 cycles of 95ºC for 15s, then 60ºC for 1
minute. The melt curve stage consisted of 95ºC for 15s, then 60ºC for 1 minute, then
95ºC for 15s. qPCR was performed on a QuantStudio5 Real-Time PCR System (Thermo
Fisher Scientific; serial number: 272530299) and analyzed using the associated cloudbased Design and Analysis software (Thermo Fisher Scientific; version 2.5.1). Gene
expression (2–∆∆Ct) was calculated using fold change. PCR efficiencies were assessed
using the LinRegPCR software version 2016.1 and determined to be above 1.80. An
endogenous control was included in each 384-well plate to ensure that run efficiencies
were comparable and that normalizations to the reference gene could be made between
plates (Supplementary figure 3-2).
Table 3-2. Summary of RT-qPCR primers used in this study.
Gene
name
RPS20
EF1a_2
EF1a_3
18S
GAPDH
CX6C1

Accession
number
NM_0011
24364.1
NM_0011
24339
NM_0011
24339
XM_0215
88520.1
NM_0011
24246
FR904651
.1

Sequence (5’-3’)
F: CCGCAATGTCAAGTCTCTGG
R: ACTGTGCAGGTCGATCAAAC
F: TGCCCCTGGACACAGAGATT
R: CCCACACCACCAGCAACAA
F: CGCACAGTAACACCGAAACTAAT
TAAGC
R: GCCTCCGCACTTGTAGATCAGATG
F: CCCAAATCAAGTCCAATTCACA
R: CTGTCTTCTCCTCCCCTCCA
F: TGACCACAGTCCACGCCTAC
R: GCAGGGATGATGTTCTGGTG
F: GCCTGCAATGCGAGGACTCC
R: TTCCTTGGTTCTGTTACGCCGTAC

Amplicon
size (bp)

Reference

202

This study

90

Semple et al.
2018

134

This study

106

This study

103

This study

114

This study

104

IL-8
IL-17a
TGFb
IL-10
MYD88
JAM-1a
Occludin
Muc2
Tricellulin
Ecadherin
Villin 1
Claudin
15
Claudin
28B
ZO-1

NM_0011
40710
GW57423
3
EU08221
1
NM_0012
45099.1
NM_0011
36545
XM_0215
64368.2
XM_0216
01275.2
XM_0369
68565.1
XM_0369
77099.1
XM_0215
85993.2
XM_0215
79240.1
XM_0369
87534.1
NM_0011
95160.1
XM_0369
63739.1

F: ATTGAGACGGAAAGCAGACG
R: CGCTGACATCCAGACAAATCT
F: TGGTTGTGTGCTGTGTGTCTATGC
R: TTTCCCTCTGATTCCTCTGTGGG
F: AGTTGCCTTGTGATTGTGGGA
R: CTCTTCAGTAGTGGTTTGTCG
F: CCATCAGAGACTACTACGAGGC
R: TCTGTGTTCTGTTGTTCATGGC
F: GACAAAGTTTGCCCTCAGTCTCT
R: CCGTCAGGAACCTCAGGATACT
F: TGAGGATGGAAGTCCGCAAC
R: GTACCACAGTCCGAAGCACA
F: GACAGTGAGTTCCCCACCAT
R: AGCTCTCCCTGCAGGTCCTT
F: GCACTCCGCACTTTTACCT
R: TTCACATGGTTGGACTGGCG
F: TTTAGCAGGGGCAAAGGTGA
R: TTCACACGCAGTCACTCAGC
F: ACTACGACGAGGAGGGAGGT
R: TGGAGCGATGTCATTACGGA
F: CATGTGGAGTGGAGGGAAGT
R: TCCTCTTTCTTGGTGGGGTC
F: GGCACGTCTGAGAAACAACC
R: TAGGAAGTGGCAGCCTGACT
F: CTCACTCTACATCGGCTGGG
R: CACAGAACTAGCAGCCTTGGA
F: CAAAGCCAGTGTATGCCCAG
R: CAGCTTCATACTCGGCCTGA

136
136
191
165
110

Wang et al.
2020
Wang et al.
2020
Wang et al.
2020
Wang et al.
2020
Wang et al.
2020

98

This study

101

This study

144

Wang et al.
2020

112

This study

107

This study

234

This study

92

This study

124

This study

119

Wang et al.
2020

3.3.11 Statistical analyses
All statistical analyses were done using GraphPad Prism software version 7.0a.
Survival analysis was done using the Mantel-Cox test. Nonparametric data were
statistically compared with a one-way ANOVA and Dunn’s multiple comparisons test.
Experiments with two factors were compared with a two-way ANOVA and Tukey’s
multiple comparisons test. Gene expression data were compared with a two-way
ANOVA and Sidak’s multiple comparisons test.
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3.4 Results
3.4.1 Supplementation of Chinook salmon with LAB strains does not
significantly improve survival to Vibrio anguillarum challenge.
To assess the physiological response of fish to probiotic supplementation in the
context of Fam56_all_ttm
a pathogenic challenge, a field trial was designed (Figure 3-1).
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3.4.2 Lactic acid bacteria supplementation does not increase weight
of fish prior to or during an active infection.
To assess whether the strains used in this study had a significant impact in the
growth of Chinook salmon, weight was measured prior to the beginning of
supplementation and after two weeks of probiotic administration, though prior to
infection (Figure 3-3 A). The percent weight gain for each individual was determined
and the median percent weight gain plotted. Individuals supplemented with P. acidilactici
18MA/5M had a significantly higher percent weight gain compared to the L. reuteri 830supplemented group, although differences were not statistically significant between either
probiotic group with the control or vehicle groups, as determined by a non-parametric
one-way ANOVA (Kruskal-Wallis) and Dunn’s multiple comparisons test. During the
infection challenge, the weight of the sampled individuals was recorded, and the specific
growth rate was determined relative to the average weight per family on day 0. There
were no statistically significant differences between or within groups (two-way ANOVA
and Tukey’s multiple comparison test; Figure 3-4 B), and family of origin had no
substantial impact on weight gain, as determined by the specific growth rate
(Supplementary figure 3-3).
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Days post-infection

before injections with V. anguillarum (day 0). Statistical significance was determined by
a non-parametric one-way ANOVA (Kruskal-Wallis) and Dunn’s multiple comparisons
test. (B) Fish weight was measured on five occasions (0, 1, 3, 7, 14 dpi) and the average
weight per family at day 0 was used to establish an initial baseline. Specific growth rate
(SGR) was determined as 100*[ln(WDN) – ln(Fam. avg. WD0)]/N, where N is the
sampling day. Statistical significance was determined by a two-way ANOVA and
Tukey’s multiple comparison test (* P = 0.0309; † P = 0.0276). Boxes represent first and
third quartile values, horizontal lines denote medians, and whiskers encompass maximum
and minimum values.

3.4.3 Expression of tight junction and immune mRNAs was
unchanged in the hindgut tissue during infection.
To investigate whether the LAB strains supplemented could modulate gut barrier
function and immunity at the transcript level, the expression of a panel of tight junction
109

molecules was assessed through RT-qPCR (Figure 3-5). Given that there were apparent
family-specific differences in survival, priority was given to individuals of family 56, as
this family displayed a 15% survival advantage in the L. reuteri LRE2-supplemented
group compared to the control and vehicle groups (Figure 3-2 C). Hindguts of
individuals sampled on days 0, 3, 7, and 14 were included in the study to assess the shortterm (3 dpi) and medium- to long-term (7 and 14 dpi, respectively) effects on tight
junction and immune markers relative to the day 0 baseline. The expression of barrierforming molecules, such as ZO-1, JAM-1a, Occludin, E-cadherin, Tricellulin, and
Claudin 15 was not significantly changed over the course of the infection challenge
(Figure 3-5 A-F). Similarly, the expression of Mucin 2, which is the major gel-forming
molecule in the intestinal mucus, and Villin 1, which regulates intestinal epithelial
morphology, was unchanged (Figure 3-5 H, I; Van der Sluis et al. 2006; Ubelmann et al.
2013). There is an apparent increasing trend in the expression of the pore-forming
molecule Claudin 28B in the group supplemented with L. rhamnosus GR1 and L. reuteri
RC14 on day 3, however the biological significance of these trends is questionable due to
the high variability between individuals (Figure 3-5 G). Statistical significance was
assessed with a 2-way ANOVA and Sidak’s multiple comparisons test.
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The expression of several immune markers was assessed to investigate the effect
LAB supplementation on pro- and anti-inflammatory molecules during the infection
challenge. The expression of IL-8 is moderately increased in the groups supplemented
with L. reuteri 830, L. rhamnosus GR1 and L. reuteri RC14, and P. acidilactici
18MA/5M on day 7 (Figure 3-5 A). The expression of IL-10 was significantly increased
in the group supplemented with L. reuteri 830 on day 7 post-infection (Figure 3-5 B);
statistical differences were not present within or between groups otherwise (2-way
ANOVA and Sidak’s multiple comparisons test, P > 0.05). The expression of
proinflammatory molecules IL-17a, TGFβ, and MyD88 were likewise unchanged
between and within groups (Figure 3-5 C-E).
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Figure 3-5. Relative expression of immune molecules in the hindgut tissue. Gene
expression data points are displayed as mean fold change (normalized to RPS20) of
individual biological replicates. Statistical significance was assessed with a 2-way
ANOVA and Sidak’s multiple comparisons test. Error bars represent means ± SD.
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3.5 Discussion
This field trial showed that supplementation with candidate probiotic strains
herein tested did not lead to an increase in weight gain, survival advantage, nor an
upregulation in tight junction and immune molecules in the hindgut tissue of Chinook
salmon challenged intraperitoneally with V. anguillarum over several weeks of study
duration. When juvenile Chinook salmon were challenged with V. anguillarum, there was
variable survival across the four candidate probiotics tested, with L. reuteri LRE2 and P.
acidilactici 18MA/5M conferring a non-statistically significant survival advantage of
15% relative to the control and vehicle groups in families 56 and 100, respectively. This
highlighted family-specific differences in survival in response to the different probiotic
treatments (Figure 3-2 B-F). Though not statistically significant, these data suggest that
the benefits due to probiotic supplementation, at least in the context of a bacterial
infection, might be influenced by fish genetic factors and disparities in immune
competence.
Family-specific differences in survival, fitness, and immune competence have
been described in the literature (Bonnet et al. 1999; Johnson et al. 2004; Yáñez et al.
2013; Semple et al. 2018). For instance, genetic polymorphisms impacting major
histocompatibility (MHC) loci in Atlantic salmon and rainbow trout have been associated
with disease resistance and susceptibility (Miller et al. 2004). Additionally, epigenetic
modifications such as DNA methylation patterns, histone modifications and variants,
noncoding RNAs, as well as chromatin architectural remodelling can impact host fitness
and coping mechanisms (Granada et al. 2017). Transgenerational epigenetic inheritance
has been described in several vertebrate species, including some fish species (Knecht et
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al. 2017). Changes in DNA methylation patterns has been linked to phenotypic variation,
including early sexual maturation and development, salt adaptation, and growth
performance (Gavery and Roberts 2017). It is, therefore, plausible that epigenetic
differences can contribute to inter-family organismal development and immune function,
as well as their response to probiotic supplementation. In practical terms, this may
suggest propagation of only families that have a higher chance of growth and survival.
Additionally, inter-female variation in egg size, ovulation timing, and fertilization
can also contribute to differences in the uniformity of triploidization. Genotypic factors
that impact the surface-to-volume ratio of the egg, meiotic timing, and susceptibility for
retention of the polar body, can affect the uniformity of the induced polyploidy (Johnson
et al. 2004). The result is genetic mosaicism, in which a proportion of the cells of an
individual are triploid and some are diploid (Johnson et al. 2004). This can also impact
survival and how well a given family performs in response to probiotic supplementation.
As such, additional measurements that confirm the induced polyploidy in the tissues of
interest, such as flow cytometry, can be helpful in determining whether the inter-family
variability is a result of lack of uniformity in the ploidy of the cells of an organism.
No appreciable increase in weight or specific growth rate was observed either
prior to (Figure 3-3 A) or over the course of the infection trial (Figure 3-3 B) in either
one of the probiotic treatments relative to the control or vehicle groups. Although there
are some examples of growth promotion mediated by LAB supplementation in salmonids
(Nikoskelainen et al., 2001; Vendrell et al., 2007; Ramos et al., 2015), there are also
cases in which improvements in weight gain were not found (Zokaeifar et al. 2012).
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Although the underlying mechanism through which beneficial microbes promote
weight gain is not known, it has been proposed that these bacteria enhance nutrient
absorption by facilitating the metabolism of otherwise indigestible nutrients (Langlois et
al. 2021). As such, it is likely that the candidate probiotics herein tested lacked the
metabolic repertoire necessary to facilitate digestion to the degree necessary to
appreciably affect weight gain within the experimental window. Alternatively, the
method of infecting the fish with the pathogen results in an invasive disease not amenable
to orally ingested probiotic amelioration. Another explanation could be that the probiotic
strains did not have sufficient time to reach an active metabolic state to influence the
host. These hypotheses warrant further investigation.
There is currently no consensus in the literature regarding the ideal window for
probiotic administration in salmonids. Some studies have reported a significant reduction
in mortality and morbidity in the context of a bacterial challenge and robust stimulation
of the innate immune response (cellular and humoral parameters) in as few as 14 days of
supplementation (Langlois et al. 2021). However, in rainbow trout supplemented with
Enterococcus casseliflavus NC0209951 and challenged with S. iniae, the serum IgM and
C3 levels were found to be increased only after 8 weeks of supplementation (Safari et al.
2016). Similarly, a reduction in A. salmonicida burden in the hindgut of brown trout was
reported after 4 weeks of supplementation with L. lactis CFLP 100 and L. mesenteroides
CLFP 196 (Balcázar et al. 2009). These findings beg the question of what an appropriate
supplementation window would be given the experimental design and research question
that this study aimed to address, which can only be answered empirically. As such, future
studies should conduct preliminary trials examining the parameters of interest (ie. growth,
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survival, morbidity, immune stimulation, stress) in various supplementation timelines to
further improve the study design and help inform practices for the industry.
Although there were little to no differences in the relative expression of the tight
junction molecules assessed at any of the timepoints (Figure 3-4), it is important to note
the considerable variability between individuals. This is a common pattern in trials using
outbred fish (Semple et al. 2018), but the reason why this is observed in siblings of the
same cross is unclear. One potential explanation is that even within families, disparities
exist in terms of growth, as some individuals might be more aggressive feeders, resulting
in an ingestion of larger amounts of the beneficial microbes compared to its siblings. Due
to resource constraints, the analysis of the hindgut tissue of all five fish families was not
feasible, but a more comprehensive study might shed light on inter-family differences
that potentially explain the differences in survival observed. In addition, the knowledge
about the physiological function of the TJ molecules assessed in this study is based on
detailed functional studies in mammals, but similar studies in fish are still limited.
The complex milieu of the salmonid gut is comprised of several inter-dependent
factors. These include a rich microbial community, mucosal epithelial cells, secreted
antimicrobials and antibodies, mucus, microbial metabolites, and resident host immune
cells, which together greatly impact organismal health (Merrifield et al. 2010). The
integrity of the intercellular junctions between adjacent epithelial cells has been proposed
as a key determinant of mucosal homeostasis, and damage to the barrier is increasingly
being recognized as a hallmark of the pathophysiology of several chronic gastrointestinal
disorders in humans (Bron et al. 2017). Since probiotic-mediated improvement of gut
barrier function has been positively associated with health benefits in several vertebrate
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species (Bron et al. 2017), we sought to investigate whether the strains herein tested
could modulate gut barrier function and immunity at the transcript level in Chinook
salmon.
Tight junctions consist of large, dynamic protein complexes that form the
circumferential seal between adjacent epithelial cells. Some of the main protein families
found in TJs are claudins, occludins, junction-associated membrane proteins (JAM), and
zonula occludens (ZO-1). In order to orchestrate the preclusion of luminal contents and
enable the passage of ions and nutrients, the epithelial barrier must have both ‘fence’ and
‘gate’ capabilities. The selectively permeable transport of molecules across the epithelial
barrier is facilitated by claudin isoforms, as well as occludin and other adjacent
molecules, and their selectivity is based on molecule size and electrical charge (Vikström
et al. 2008; Cummins 2012; Sundell and Sundh 2012).
Therefore, the panel of TJ molecules selected was representative of four main
characteristics of the intestinal epithelium. The first is the barrier-forming cell-cell
connections represented by zo-1, jam-1a, ocldn, ecadh, and mald2 (tricellulin; Schug et
al. 2019). The second is the pore-forming ability that enables the selectively permeable
transport of compounds across the epithelial barrier, represented by cldn15 and cldn28b
(Bagnat et al. 2007; Tipsmark et al. 2010). The third is mucus secretion, represented by
muc2, which is a key structural component of the colonic mucus layer (Van der Sluis et
al. 2006). The fourth characteristic of interest is the apical surface projections that form
the brush border membrane, represented by villin (vil1), which is a Ca2+-dependent actinbinding protein involved in the structural remodelling and nucleation of microvilli
(Friederich et al. 1999; Ubelmann et al. 2013).
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The intestinal mucosa is a prime target organ for immunomodulation given by
oral probiotic administration. Although numerous studies over the last decades have
examined the potential for promoting immune homeostasis locally and systemically
through the supplementation of beneficial microbes, the underlying mechanism remains
poorly understood. The present study sought to better understand the relationship
between immune modulation in the hindgut and candidate probiotics in during a bacterial
infection. The selection of the immune genes assessed was based on their function in
bacterial stimulation (il8, myd88), promoting pathogen clearance and autoimmunity
(il17a), as well as anti-inflammatory markers (il10, tgfb).
In spite of extensive inter-individual differences in relative expression, there was
no clear trend indicating that administration of the candidate probiotics had a significant
impact on the immune markers assessed compared to the control and vehicle groups
(Figure 3-5). Our data are in contrast with several studies in salmonid species as well as
finfish in general, which largely suggest that supplementation with LAB results in an
upregulation of cellular and humoral immune parameters at the intestinal mucosal
interface (Hoseinifar et al. 2018; Ringø et al. 2018; Langlois et al. 2021). For instance, P.
acidilactici 18MA/5M has been shown to significantly upregulate the expression of
proinflammatory markers IL-1β, TNFα, and IL-8 in Atlantic salmon (Abid et al. 2013;
Jaramillo-Torres et al. 2019). The same strain was also used in a study in rainbow trout,
which reported the upregulation of IL-1 and IL-8 and a decrease in the expression of IL10, while simultaneously protecting the intestinal epithelium from inflammation and
damage to the tissue (Al-Hisnawi et al. 2019).
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In rainbow trout, dietary Lacticaseibacillus rhamnosus GG (ATCC 53103)
resulted in an increase in respiratory burst activity, serum complement activity, and
serum immunoglobulin levels, which was associated with a survival advantage against
Aeromonas salmonicida infection (Nikoskelainen et al. 2001, 2003). Similarly,
administration of Lactiplantibacillus plantarum subsp. plantarum CLFP 3 to rainbow
trout led to an upregulation in the expression of IL-1β, TNFα, and IL-10 in the head
kidney and IL-8 and IgT were upregulated in the intestine during infection with
Lactococcus garviae. The supplemented fish also had a significantly lower mortality rate
compared to the control group, suggesting that probiotic-mediated modulation of immune
parameters might be a mechanism for improvements in survival to bacterial pathogens
(Pérez-Sánchez et al. 2011).
Nevertheless, a cautionary note must follow that the observed effects are only
descriptive of the host and microbe species in which these studies were conducted. The
vast genetic and physiological differences in both hosts and beneficial microbes preclude
sweeping generalizations and encourages the technical use of the term ‘probiotic’
exclusively in the cases for which reputable investigations have provided evidence for the
alleged benefits. Furthermore, a more comprehensive analysis including a larger pool of
sampled individuals can enhance the power and inference ability of these analyses. Also,
the investigation of the innate and adaptive immune response in other relevant immune
organs in teleosts (such as head kidney, spleen, gills, and skin) would provide a clearer
picture of the effects of LAB supplementation in Chinook salmon during infection.
In considering why our study did not show the effects reported by others, the
delivery method comes into question. The transit time for food and the bacteria
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embedded in the pellet through the intestine of the salmon is approximately 12h (Sveier,
Wathne and Lied 1999). This means the dried organisms must hydrate, become
metabolically active and ‘escape’ their sodium alginate covering then make an impact via
the microbiota and epithelial layer before being excreted. Moreover, the primary energy
source of LAB strains are carbohydrates and an increase in the abundance of these genera
has been associated with a carbohydrate-rich fish diet (Ringø et al. 2016). This thus raises
the question of whether the fishmeal diet had the nutritional requirements to support LAB
growth. Future studies should examine whether the inclusion of a prebiotic growth
stimulant and a coating other than alginate could provide a faster and better delivery
system for these fish.
In conclusion, it is hoped that this research will help inform future studies in order
to optimize the benefits of probiotic strains and gain insights into their mechanisms, such
as via improving the intestinal barrier function. Ideally, once strains and delivery are
selected and feed conversion rates are proven, a better field trial than deliberate
intraperitoneal infection, would be to feed fish in an aquaculture set-up and monitor the
incidence and severity of naturally occurring infections over time. This would then
demonstrate the validity of the concept and gather information on the cost-benefit of
probiotic supplementation in salmonid aquaculture.
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3.7 Supplementary material
Supplementary table 3-1. Nutrition facts of the fish feed administered to Chinook
salmon as provided by Taplow Feeds, FirstMate Animal Nutrition.
Particle diameter

Moisture
Total protein
Fish meal
Total fat
Fish oil
Amino acids
Methionine
Cystine
Lysine
Tryptophan
Threonine
Isoleucine
Histidine
Valine
Leucine
Arginine
Phenylalanine
Taurine
Vitamins
Vitamin A
Thiamine
Riboflavin
Niacin
Pantothenic acid
Pyridoxine
Biotin
Folic Acid
Vitamin B12
Vitamin C
Vitamin D3
Vitamin E
Choline

6.5mm
Dry Matter Basis

Units
%
%
%
%
%

As Fed
6
42.49
51.8
28.47
21.7

%
%
%
%
%
%
%
%
%
%
%
%

1.39
0.56
3.55
0.52
1.82
1.97
1.2
3.61
3.31
3.56
1.72
0.35

1.48
0.60
3.78
0.55
1.94
2.10
1.28
3.84
3.52
3.79
1.83
0.37

1.33
0.56
3.38
0.51
1.75
1.91
1.14
3.46
3.21
3.4
1.69
0.33

1.41
0.60
3.60
0.54
1.86
2.03
1.21
3.68
3.41
3.62
1.80
0.35

IU/kg
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg
µg/kg
µg/kg
µg/kg
mg/kg
IU/kg
IU/kg
mg/kg

2007.76
5.98
9.54
218.37
29.09
4.52
945.78
2413.79
369.39
29.4
1927.45
53.64
3348.84

2135.91
6.36
10.15
232.31
30.95
4.81
1006.15
2567.86
392.97
31.28
2050.48
57.06
3562.60

2087.76
6.52
9.47
222.18
29.8
4.7
977.8
2505.26
349.75
31.3
2004.25
55.73
3222.98

2221.02
6.94
10.07
236.36
31.70
5.00
1040.21
2665.17
372.07
33.30
2132.18
59.29
3428.70

45.20
30.29

As Fed
6
40.88
54.5
25.37
18.9

8.5mm
Dry Matter Basis
43.49
26.99
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Minerals
Calcium
Phosphorous
Sodium
Potassium
Magnesium
Manganese
Iron
Copper
Zinc
Selenium
Chloride
Iodine

%
%
%
%
%
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg
%
mg/kg

2.01
1.66
1.55
1.02
0.13
27.55
126.6
9.29
128.19
1.34
2.21
4.02

2.14
1.77
1.65
1.09
0.14
29.31
134.68
9.88
136.37
1.43
2.35
4.28

1.9
1.6
1.47
1
0.13
30.77
128.23
10.01
129.5
1.29
2.09
4.18

2.02
1.70
1.56
1.06
0.14
32.73
136.41
10.65
137.77
1.37
2.22
4.45

Supplementary figure 3-1. Comprehensive gene stability as assessed using the
RefFinder software (Xie, Xiao and Chen 2012;
https://www.heartcure.com.au/reffinder/). The reference gene RPS20 was selected due to
its combined stability and efficiency compared to the other potential reference genes.
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Supplementary figure 3-2. Endogenous RPS20 quality control to ensure that run
efficiencies were comparable. Samples were run in technical triplicates and the mean
raw Ct value was plotted. Two mastermix preparations were made, and genes were
compared to the respective RPS20 normalization controls (ie. RPS20_1 for ZO-1, JAM1a, Ocldn, EcadH, and IL-8; RPS20_2 for IL-17a, TGFb, IL-10, Tricellulin, Cldn15,
Muc2, Vil1, MYD88, and Cldn28B).
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Supplementary figure 3-3. Specific growth rate of Chinook salmon from five different
family crosses during infection with Vibrio anguillarum. Differences within and between
groups were not statistically significant (two-way ANOVA and Tukey’s multiple
comparisons test). Boxes represent first and third quartile values, horizontal lines denote
medians, and whiskers encompass maximum and minimum values.
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Chapter 4
4. General discussion
4.1 The importance of microbes in aquaculture and study
summary
Microbes are ubiquitous in aquaculture systems, and their effective management
and pathogen control are vital for maximizing production. The supplementation of
beneficial microbes has been increasingly recognized as a promising eco-friendly
microbial management strategy (Langlois et al. 2021). Although several recent reports
emphasize the benefits of probiotic supplementation in finfish, very few have
endeavoured to characterize their effects at a molecular level in the gut, particularly in
salmonids.
The primary goal of this project was to identify promising probiotic candidate
strains for supplementation in salmonid aquaculture through the modulation of intestinal
mucosal immunity and gut barrier function, with the intent that these could improve
growth and disease resistance. The study design employed a combinatorial approach that
integrated both in vitro and in vivo analyses. First, the rainbow trout intestinal epithelial
cell line RTgutGC was used as a model for understanding the molecular response of the
host to several strains of lactic acid bacteria (LAB) and to assess whether these microbes
could protect the intestinal epithelium from damage due to Vibrio anguillarum. The
second objective was to examine these effects at the organismal level through a field trial
conducted in British Columbia. On site, juvenile Chinook salmon (3.5-17g) were
supplemented with select LAB strains for two weeks, then infected with V. anguillarum.
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The growth and mortality were recorded, and the expression of several tight junction and
immune genes in the intestine was assessed to determine whether probiotic
supplementation could maintain or improve the barrier function of the gut in the context
of a bacterial challenge.
The main conclusion from this project is that the LAB strains herein examined did
not exhibit a strong ability to modulate barrier function on an intestinal cell line, or
enhance disease resistance in live salmonids. Although no deleterious effects were
observed, the benefits provided to fish must be of sufficiently large magnitude to offset
the costs in sourcing and administering the beneficial microbes and therefore make
probiotic supplementation a viable, sustainable, and affordable solution for the industry.
In Chapter 2, LAB co-incubation did not induce an increase in the expression of
several key tight junction molecules assessed. The strains originating from humans did
not appreciably upregulate immune molecules. Some of these isolates did increase the
expression of pro-inflammatory cytokines, but the experimental evidence was too
preliminary to predict how this would affect live fish and so the suitability of these strains
as probiotic candidates must be investigated further. Moreover, exposure to V.
anguillarum was associated with a pronounced decrease in the expression of key TJ
molecules, except for occludin, which was unexpectedly increased, perhaps signaling a
defensive reaction by the host. The results appeared to suggest that the pathogen
potentially targets occludin as a potentiator of the inflammatory response. This in turn
further exacerbates the damage to the intestinal barrier and enables pathogen invasion
into the circulation (Van Itallie et al. 2010). Interestingly, LAB pre-treatment mitigated
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the injury caused by the pathogen, even though the expression patterns of several tight
junction and immune molecules were not substantially altered.
While the proposed approach is informative, future studies would benefit from
validating these findings in systems that more closely mimic the physiological conditions
of the fish gut. In particular, the use of gut-on-chip and organoid systems that can
reconstruct the basic intestinal architecture allow for the study of host-microbe
interactions in vitro in a more physiologically relevant environment (Drieschner et al.
2019a, 2019b). Furthermore, the study of the host response to bacteria is constrained by
the optimal growth conditions of both organisms. While the RTgutGC cells are cultured
at room temperature in an aerobic environment, most LAB are grown optimally at around
37˚C and in the absence of oxygen. As such, the differences in temperature and oxygen
levels can affect the metabolic activity of the candidate probiotics, presumably limiting
the potential benefits on the host. Not only that, the fish swim in water that is well below
room temperature (around 4˚C). This means the intestinal environment is not conducive
to LAB reaching logarithmic growth unless they were to colonize and have access to
growth factors. This raises the question of delivering the strains with prebiotic
compounds or in an active growing stage. The latter could be achieved on a fish farm by
using large fermentation tanks, then allowing the bacteria in suspension to adsorb to food
pellets, just prior to feeding the fish. Experiments like this are worthy of investigation in
order to determine the potential for probiotic organisms to improve yields.
The present study also examined changes at the transcript level. However, these
differences in mRNA abundance might not always correlate to changes at the protein
level, as several post-transcriptional and post-translational modifications can affect the
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physiological function of the tight junctions (Shen, Weber and Turner 2008). Future work
would benefit from further validating these findings through methods such as Western
blotting and immunofluorescence, coupled with automated quantification of the staining.
Although there are few commercially available fish-specific antibodies, some studies
have had success using human- or murine-specific antibodies that target the conserved
protein epitopes (Pumputis et al. 2019).
In Chapter 3, while supplementation of select LAB strains did not lead to a
significant survival advantage of Chinook salmon against an infection challenge with V.
anguillarum, there were appreciable family-specific improvements in survival.
Aquaculture farmers use different families of fish, making it theoretically possible to
improve the results by matching responder families with probiotic strains.
We had hypothesized that the gene expression of several tight junction and
immune molecules would be enhanced by the probiotic strains. The fact that there was
little difference between the control and vehicle groups on the RTgutGC cells could have
one of several explanations. For example, it is known that lactobacilli GG does modulate
barrier proteins in Caco-2 intestinal cells (Johnson-Henry et al. 2008; Miyauchi, Morita
and Tanabe 2009; Karczewski et al. 2010). So, either there are major differences between
the cells and receptivity to this strain, or the suspending fluid and incubation environment
somehow inhibited an interaction, or there are other factors not identified that interfered
with the signaling. Nevertheless, based on the experimental data, the candidate fish
probiotic strains showed no substantial evidence of being able to confer health benefits to
Chinook salmon in the context of this experiment.
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Although the use of models has been instrumental for foundational advances in
the understanding of the physiology of related organisms, there are no substitutes for
investigating the intended target organism directly, whenever possible. The present study
examined the suitability of LAB supplementation in Chinook salmon in the context of a
pathogen challenge. The advent of ethically conducting experiments in the target host
species enables the direct observation of the effects of the treatments in the context of the
complexities of the organism’s physiology. This is especially important as it pertains to
investigating host-microbe interactions. For example, it is not uncommon that hostmicrobe studies conducted in rodent models do not hold true for human hosts (Nguyen et
al. 2015). As such, aquaculture research can greatly benefit from studies of fish in tanks
or the wild. For the latter, feeding non-pathogenic LAB into the river or sea should not
constitute an environmental hazard, unlike adding Vibrio pathogens. The LAB will not
survive for long in the water, and if they are ingested by fish or other mammals, they will
not colonize or persist. Therefore, their activity is short-acting and unlikely to have
negative environmental consequences. This makes it all the more important to deliver
physiologically active organisms that are taken up rapidly during the feeding frenzy.
In addition to ethical issues, a drawback of animal trials is that they are time- and
resource-intensive and the high complexity of the system does not lend itself to a fine
control of variables that can affect the fish response to microbial management strategies.
Therefore, some effects can be masked. To reduce the risk of this happening,
gnotobiotic models could be considered if they are feasible in a research laboratory
(Perez-Pascual et al. 2021).
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Clearly, the mode of delivery and the metabolic state of the living microbes are
crucial. Although some studies have detected the presence of the supplemented microbes
in the fish intestine, none have investigated whether the microbes are functionally and
metabolically active in the fish gut. A powerful approach that could be employed to
address this knowledge gap is the integration of multi-omic datasets, which integrate
metagenomic and metabolomic tools to identify enriched pathways and the key molecules
being produced by the microbiota as a snapshot of the functional state of the system (Li et
al. 2017; Uengwetwanit et al. 2020). Furthermore, the development of novel delivery
vehicles appropriate for aquaculture systems can ensure the targeted release of the living
microbes in the intended organ (ie. the gut).

4.2 Final considerations
The complex network of interactions between microbes and their hosts exists on a
continuum from pathogenicity to mutualism and can be described as an interdependent
triad of host-microbe, host-pathogen, and microbe-microbe interactions (Boutin et al.
2013). As such, the importance of microbes in aquaculture systems cannot be overlooked.
A better understanding of the structure and function of organisms in aquatic settings will
help guide strategies to optimize fish health and their productivity as a food supply.
This thesis investigated the development of tools for the assessment of hostmicrobe interactions in salmonids systems. Although further investigation of the
phenomena discussed here is necessary, it is hoped that the findings will contribute to
greater investment in microbial management strategies that are effective, economically
sound, and environmentally sustainable. Future studies that focus on the nexus of
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industry goals and academic interests can bridge the gap between the technologies needed
and the applicability necessary for meeting production goals. Pathogens will always exist;
but rather than try to eradicate them using antimicrobial agents which themselves can be
toxic and destroy commensal organisms, the use of probiotic strains should continue to be
explored to improve host immune performance and animal welfare and support a healthy
gut microbiota.
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